Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3007821	p-glu/0	mmol/l (mmol/l)	1315	1834	0.00%
3007821	p-gluk-0h	mmol/l (mmol/l)	549	765	0.00%
3007821	p-gluk-0	mmol/l (mmol/l)	197	264	0.00%
3007821	p-gluk0	mmol/l (mmol/l)	168	192	0.00%
3007821	p-gluk0	— (—)	112	134	100.00%	Distribution not available
3007821	p-gluk0h	mmol/l (mmol/l)	61	69	0.00%
3007821	p-gluk-0	— (—)	26	26	100.00%	Distribution not available
3007821	p-glu/0	— (—)	25	25	100.00%	Distribution not available
3007821	p-glukoosi,0-näyte	mmol/l (mmol/l)	16	16	0.00%
3007821	p-gluk-0h	— (—)	10	10	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Persons with potential health hazards related to communicable diseases

705

863

8.36

307.65

1.5

1.4

5.26

5.39

mmol/l

1.37

694

806

Contact with and exposure to communicable diseases

674

737

9.45

307.65

1.5

1.4

5.21

5.32

mmol/l

1.07

664

688

Postpartum care and examination

319

148

14.32

262.34

1.5

1.3

4.91

5.59

mmol/l

8.43

314

142

Outcome of delivery

252

191

8.38

150.29

1.5

1.3

4.97

5.68

mmol/l

9.51

252

182

Other symptoms and signs involving the urinary system

128

161

8.17

95.17

1.3

5.88

6.00

mmol/l

0.26

128

152

Single delivery by forceps and vacuum extractor

131

121

6.69

65.75

1.7

1.3

4.92

5.80

mmol/l

7.59

125

115

Single delivery by caesarean section

155

161

5.64

65.31

1.6

1.3

5.01

5.89

mmol/l

9.26

146

153

Delivery

216

354

3.25

45.87

1.5

1.3

5.11

5.99

mmol/l

18.05

206

332

Single spontaneous delivery

214

354

3.24

45.35

1.6

1.3

5.09

5.99

mmol/l

18.76

206

332

Delivery, wide proxy

178

266

3.59

43.64

1.6

1.3

5.04

6.04

mmol/l

19.56

171

247

Diabetes mellitus in pregnancy

287

733

2.56

43.06

1.8

1.3

5.37

5.06

mmol/l

3.46

270

706

Maternal care for other known or suspected fetal problems

209

460

2.95

40.42

1.8

1.4

4.92

5.21

mmol/l

4.70

202

439

Persons encountering health services for other counselling and medical advice, not elsewhere classified

550

1657

1.90

38.93

1.4

5.63

5.60

mmol/l

0.19

519

1568

Other maternal disorders predominantly related to pregnancy

388

1150

2.14

38.58

1.7

1.3

5.37

5.36

mmol/l

0.00

368

1091

False labour

222

558

2.52

32.13

1.6

1.4

5.09

5.32

mmol/l

1.50

217

532

Antenatal screening

151

276

3.11

30.76

1.6

1.3

5.03

5.74

mmol/l

9.02

146

264

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

278

820

2.22

30.73

1.6

1.5

4.97

5.07

mmol/l

0.67

271

784

Persons encountering health services in other circumstances, wide

560

1661

1.75

30.33

1.3

1.4

5.64

5.60

mmol/l

0.25

523

1572

Other obstetric conditions, not elsewhere classified

281

838

2.20

30.31

1.6

1.5

4.97

5.10

mmol/l

0.91

272

802

Labour and delivery complicated by fetal stress [distress]

198

521

2.56

30.07

1.6

1.4

5.02

5.09

mmol/l

0.38

188

500

Supervision of high-risk pregnancy

133

250

3.24

29.73

1.7

1.3

5.16

5.72

mmol/l

6.34

127

238

Obesity due to excess calories

256

1237

2.08

26.53

1.7

1.4

5.62

5.51

mmol/l

0.78

239

1170

General examination and investigation of persons without complaint and reported diagnosis

328

887

1.98

25.81

1.3

1.4

5.62

5.55

mmol/l

0.31

305

838

Obesity

321

1684

1.90

25.52

1.6

1.4

5.65

5.51

mmol/l

1.26

301

1598

Other nutritional deficiencies

333

1747

1.87

25.34

1.6

1.4

5.64

5.50

mmol/l

1.31

314

1659

Obesity and other hyperalimentation

321

1690

1.89

25.19

1.6

1.4

5.65

5.51

mmol/l

1.26

301

1604

Obstructed labour due to malposition and malpresentation of fetus

162

622

2.48

25.04

1.6

1.4

5.05

5.27

mmol/l

2.78

156

595

Maternal care for known or suspected abnormality of pelvic organs

178

514

2.41

24.20

1.7

1.4

5.10

5.35

mmol/l

2.14

166

486

Perineal laceration during delivery

137

474

2.60

23.24

1.6

1.4

5.03

5.00

mmol/l

0.07

129

452

Other special examinations and investigations of persons without complaint or reported diagnosis

331

887

1.89

22.90

1.4

5.65

5.55

mmol/l

0.71

317

838

Complications of labour and delivery

337

1032

1.83

21.46

1.5

1.3

5.35

5.46

mmol/l

0.71

318

975

Maternal care related to the fetus and amniotic cavity and possible delivery problems

264

791

1.97

21.38

1.6

1.3

5.08

5.49

mmol/l

9.78

253

750

Disorders of lipoprotein metabolism and other lipidaemias

298

1019

1.84

20.12

1.3

6.11

5.95

mmol/l

1.20

275

963

Type 2 diabetes, definitions combined, including avohilmo

398

1404

1.68

19.45

1.4

1.3

6.49

5.47

mmol/l

40.71

359

1342

Endocrine, nutritional and metabolic diseases

398

1199

1.69

19.24

1.5

1.3

5.68

5.23

mmol/l

5.84

371

1147

Supervision of normal pregnancy

121

268

2.60

18.38

1.7

1.3

5.00

5.70

mmol/l

10.59

113

256

Care involving use of rehabilitation procedures

258

1396

1.76

16.28

1.3

5.95

5.72

mmol/l

1.48

247

1313

Maternal care for known or suspected malpresentation of fetus

125

409

2.30

15.79

1.6

1.4

5.06

5.19

mmol/l

0.35

118

388

Long labour

148

619

2.10

15.60

1.7

1.4

5.18

5.24

mmol/l

0.30

142

592

Hyperlipidaemia, other/unspecified

125

538

2.21

15.22

1.3

1.2

6.25

6.14

mmol/l

0.32

117

507

Persons encountering health services in circumstances related to reproduction

211

777

1.85

14.71

1.5

1.2

5.36

5.96

mmol/l

11.46

202

728

Gestational diabetes (for exclusion)

253

1036

1.74

14.51

1.7

1.4

5.45

5.09

mmol/l

5.87

235

999

Maternal care for other conditions predominantly related to pregnancy

135

641

2.09

14.42

1.7

1.3

5.09

mmol/l

0.01

123

612

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

263

1372

1.68

14.04

1.4

5.38

5.37

mmol/l

0.06

252

1295

Episodal and paroxysmal disorders

485

1674

1.49

13.87

1.3

1.4

5.69

5.49

mmol/l

2.52

458

1586

Pure hypercholesterolaemia

232

888

1.76

13.79

1.3

1.2

6.07

5.99

mmol/l

0.45

216

837

Speech therapy

111

510

2.19

13.40

1.2

1.3

6.11

5.87

mmol/l

0.76

105

482

Sleep apnoea, including avohilmo

348

1443

1.57

13.33

1.3

5.95

5.79

mmol/l

1.91

326

1362

Insulin, intermediate and long-acting

1131

0.29

13.27

1.2

1.3

9.76

5.79

mmol/l

3.34

1065

Headache

304

1597

1.60

13.08

1.4

5.51

5.53

mmol/l

0.13

288

1517

Hypertension, essential

289

1008

1.64

12.95

1.3

6.06

5.70

mmol/l

5.20

279

948

Type of accident

122

594

2.06

12.71

1.4

5.51

5.62

mmol/l

0.51

117

561

Gestational [pregnancy-induced] hypertension

165

895

1.85

12.48

1.4

1.5

5.36

5.26

mmol/l

0.55

158

853

Parasetamol

374

1247

1.53

12.41

1.4

5.50

5.46

mmol/l

0.23

348

1190

Pregnancy hypertension

239

1309

1.65

12.02

1.4

5.37

5.35

mmol/l

0.13

228

1242

Dorsopathies

453

1595

1.45

11.58

1.4

5.57

5.50

mmol/l

0.63

427

1509

Other dorsopathies, not elsewhere classified

438

1590

1.46

11.44

1.4

5.60

5.50

mmol/l

0.96

412

1505

Supplementary factors related to causes of morbidity and mortality classified elsewhere

127

656

1.94

11.26

1.4

5.52

5.60

mmol/l

0.32

121

621

Dental caries 1 and operation codes

319

1061

1.55

11.02

1.4

1.3

5.83

5.65

mmol/l

1.08

299

1017

Metabolic disorders

335

1383

1.51

10.78

1.3

6.01

5.76

mmol/l

2.91

313

1304

Type 2 diabetes, definitions combined

357

1441

1.48

10.48

1.4

1.3

6.57

5.51

mmol/l

30.23

321

1376

Neurological diseases

399

1384

1.45

10.32

1.4

5.60

5.44

mmol/l

1.50

375

1315

Type 2 diabetes, strict (exclude DM1)

357

1447

1.48

10.30

1.4

1.3

6.57

5.51

mmol/l

30.20

321

1381

Insulin, combination of fast acting with intermediate-acting or long-acting

1237

0.43

9.80

1.4

1.3

8.03

5.75

mmol/l

3.22

1167

Other disorders of amniotic fluid and membranes

378

2.16

9.74

1.5

1.4

4.94

5.17

mmol/l

2.41

360

Dental caries 3 and operation codes

332

1147

1.49

9.70

1.4

1.3

5.83

5.63

mmol/l

1.43

313

1093

Dental caries 3, only avohilmo

306

1036

1.51

9.69

1.4

1.3

5.84

5.61

mmol/l

1.49

290

987

Dental operations, only avohilmo

244

790

1.59

9.49

1.3

5.94

5.74

mmol/l

0.92

229

762

Mouth breathing

139

786

1.77

9.32

1.2

1.3

5.89

5.86

mmol/l

0.10

129

746

Diseases of oral cavity, salivary glands and jaws

350

1236

1.46

9.19

1.4

1.3

5.76

5.62

mmol/l

0.91

325

1185

Dorsalgia

411

1587

1.40

9.03

1.4

5.62

5.50

mmol/l

1.12

379

1503

Spinal stenosis

143

640

1.75

8.94

1.3

1.2

6.17

6.11

mmol/l

0.19

134

596

Dental pulpitis 2

249

824

1.55

8.85

1.3

5.84

5.63

mmol/l

1.09

236

792

Dental caries, including avohilmo

274

925

1.52

8.83

1.3

5.82

5.64

mmol/l

0.96

258

888

Haemorrhage in early pregnancy

138

773

1.75

8.82

1.5

1.3

5.31

5.30

mmol/l

0.01

130

739

Dental caries 1, only avohilmo

278

942

1.51

8.82

1.4

1.3

5.82

5.65

mmol/l

0.97

262

902

Dental pulpitis 2, only avohilmo

253

842

1.54

8.75

1.3

5.84

5.64

mmol/l

1.06

240

809

Dental operations

229

747

1.58

8.75

1.3

5.92

5.75

mmol/l

0.69

214

721

Dental caries 1

274

927

1.51

8.74

1.3

5.82

5.65

mmol/l

0.95

258

889

Insulin medication

1095

0.45

8.70

1.4

1.3

8.03

5.56

mmol/l

3.65

1046

Sleep apnoea

298

1389

1.46

8.39

1.3

5.99

5.84

mmol/l

1.61

274

1311

Dental caries 3

294

1022

1.47

8.27

1.4

1.3

5.83

5.62

mmol/l

1.27

278

974

Symptoms and signs involving the circulatory and respiratory systems

440

1613

1.37

8.24

1.3

1.4

5.60

5.47

mmol/l

1.66

407

1544

Hypertension

275

1050

1.48

8.22

1.3

6.07

5.67

mmol/l

5.91

267

987

Persons encountering health services in other circumstances

147

877

1.68

8.20

1.4

5.43

5.54

mmol/l

0.55

135

833

Hypertensive diseases

275

1051

1.48

8.19

1.3

6.07

5.67

mmol/l

5.90

267

988

General symptoms and signs

459

1696

1.36

8.17

1.4

5.64

5.56

mmol/l

0.71

427

1609

Persons encountering health services for examination and investigation

265

887

1.50

8.13

1.3

1.4

5.63

5.55

mmol/l

0.47

248

838

Spondylosis

160

841

1.63

7.90

1.2

1.3

6.10

5.98

mmol/l

0.64

145

788

Transient ischemic attack

144

712

1.68

7.84

1.2

1.3

5.91

6.10

mmol/l

1.43

132

671

Spondylopathies

258

1058

1.48

7.82

1.3

6.02

5.83

mmol/l

1.36

237

993

Sleep disorders (combined)

354

1669

1.39

7.75

1.3

5.94

5.66

mmol/l

3.91

329

1582

Low back pain

286

1534

1.44

7.72

1.4

5.66

5.53

mmol/l

1.02

259

1450

Statin medication

240

898

1.50

7.60

1.3

6.22

5.59

mmol/l

4.87

220

853

Fitting and adjustment of other devices

494

1.85

7.58

1.4

1.3

5.93

6.04

mmol/l

0.54

461

Symptoms and signs involving the urinary system

238

1251

1.47

7.31

1.3

5.96

5.78

mmol/l

1.30

233

1171

Symptoms and signs involving the digestive system and abdomen

398

1468

1.36

7.23

1.3

1.4

5.74

5.59

mmol/l

1.10

371

1395

Dipeptidyl peptidase 4 (DPP-4) inhibitors

179

0.00

7.20

0.0

1.2

—

5.90

—

170

Type 2 diabetes

359

1555

1.37

7.14

1.4

1.3

6.67

5.47

mmol/l

25.29

323

1484

Obesity, other/unspecified

144

891

1.62

7.07

1.5

1.4

5.80

5.50

mmol/l

2.49

134

846

Abdominal and pelvic pain

395

1468

1.35

7.00

1.3

1.4

5.71

5.59

mmol/l

0.79

361

1395

Covid-19 suspected case

573

0.28

6.99

1.4

5.03

5.40

mmol/l

1.17

543

Depression

377

1925

1.35

6.95

1.4

5.64

5.54

mmol/l

0.72

358

1819

Rotator cuff syndrome

190

925

1.53

6.95

1.2

1.3

5.95

5.97

mmol/l

0.07

177

871

Other disorders of veins

879

0.42

6.88

1.2

1.3

6.02

5.85

mmol/l

0.31

828

Complications predominantly related to the puerperium

146

917

1.60

6.78

1.5

5.08

5.32

mmol/l

2.97

141

871

Mood disorders

396

1951

1.33

6.73

1.4

5.71

5.56

mmol/l

1.37

375

1843

Mood [affective] disorders

395

1949

1.33

6.71

1.4

5.70

5.56

mmol/l

1.32

374

1841

Contraceptive management

139

599

1.64

6.71

1.4

1.3

5.55

5.91

mmol/l

4.08

132

561

Preterm labour and delivery

112

659

1.71

6.70

1.6

1.3

5.36

5.54

mmol/l

1.20

105

623

Hypertensive diseases (excluding secondary)

200

772

1.51

6.60

1.3

1.4

6.02

5.62

mmol/l

3.74

192

733

Persons encountering health services for specific procedures and health care

401

1876

1.33

6.46

1.3

1.4

5.87

5.54

mmol/l

4.25

381

1771

Other intervertebral disc disorders

298

1318

1.39

6.38

1.3

1.4

5.83

5.66

mmol/l

1.60

281

1242

Lower back pain or/and sciatica

384

2011

1.33

6.33

1.4

5.66

5.58

mmol/l

0.68

350

1915

Diabetic nephropathy, excluding more controls

253

0.20

6.31

1.2

1.4

7.70

6.73

mmol/l

—

225

Other symptoms and signs involving the digestive system and abdomen

332

1.97

6.18

1.2

1.4

5.54

5.77

mmol/l

1.10

315

Shoulder lesions

246

1062

1.42

6.09

1.3

5.96

5.87

mmol/l

0.46

228

999

Pre-eclampsia or poor fetal growth

166

1099

1.51

6.07

1.4

1.5

5.19

5.28

mmol/l

0.67

160

1048

Carpal tunnel syndrome

204

1270

1.45

6.06

1.4

1.3

5.81

5.80

mmol/l

0.04

184

1200

Gingivitis and periodontal diseases

324

1234

1.36

5.94

1.3

5.76

5.62

mmol/l

1.19

295

1183

Pain in joint

222

1029

1.43

5.82

1.4

5.62

5.55

mmol/l

0.41

209

980

Ischaemic heart disease, wide definition

215

935

1.44

5.81

1.2

1.3

6.05

6.06

mmol/l

0.09

195

885

Abnormalities of breathing

358

1612

1.32

5.67

1.3

1.4

5.76

5.47

mmol/l

5.09

333

1544

Gonarthrosis,primary

253

1144

1.39

5.66

1.3

1.2

6.04

6.01

mmol/l

0.14

229

1081

Other diseases of hard tissues of teeth

227

1201

1.41

5.65

1.3

5.85

5.60

mmol/l

1.21

210

1151

Spontaneous abortion

227

1097

1.41

5.55

1.5

1.4

5.41

5.37

mmol/l

0.22

216

1033

Other obstructed labour

165

2.32

5.51

1.4

1.3

5.52

5.39

mmol/l

0.24

156

Obesity related asthma

115

722

1.60

5.44

1.3

5.77

5.82

mmol/l

0.27

106

680

Soft tissue disorders

408

1642

1.29

5.38

1.3

1.4

5.55

5.51

mmol/l

0.33

385

1556

Other interventions on the root canals of the tooth

4.40

5.31

1.2

1.5

6.14

6.19

mmol/l

0.02

Other neurological diseases

205

1165

1.42

5.31

1.3

5.82

5.84

mmol/l

0.10

190

1096

Constipation

275

1458

1.35

5.29

1.3

5.94

5.76

mmol/l

1.32

261

1370

Other soft tissue disorders, not elsewhere classified

345

1635

1.31

5.09

1.4

5.63

5.51

mmol/l

1.25

322

1552

Disorders of the thyroid gland

366

1853

1.29

5.07

1.3

1.4

5.64

5.53

mmol/l

0.84

340

1766

Diabetic nephropathy

259

0.23

5.04

1.2

1.4

7.70

6.80

mmol/l

—

231

Pain (limb, back, neck, head abdominally)

281

1046

1.35

4.98

1.3

1.4

5.70

5.57

mmol/l

0.65

261

996

Gonarthrosis [arthrosis of knee](FG)

229

978

1.38

4.87

1.3

1.2

6.02

5.98

mmol/l

0.14

210

927

Procreative management

441

1.67

4.81

1.6

1.3

5.34

5.93

mmol/l

5.25

419

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

171

752

1.44

4.78

1.4

5.65

5.60

mmol/l

0.20

163

713

Rheumatism, unspecified

271

1.93

4.76

1.3

5.83

5.96

mmol/l

0.27

254

Lumbar disc prolapse

208

1196

1.38

4.75

1.3

5.78

5.72

mmol/l

0.36

197

1126

Gonarthrosis

202

827

1.40

4.73

1.3

1.2

6.01

5.97

mmol/l

0.17

186

785

Gastrointestinal diseases

278

1043

1.34

4.72

1.5

1.4

5.58

5.41

mmol/l

0.83

265

990

Other (not insulin) diabetes medications

325

1508

1.30

4.70

1.4

1.3

6.68

5.54

mmol/l

20.18

293

1436

STROKE

172

834

1.43

4.69

1.2

1.3

5.85

5.88

mmol/l

0.14

157

792

Angina pectoris

151

696

1.47

4.64

1.3

1.2

6.16

6.14

mmol/l

0.07

138

662

Mood disorders, excluding more controls

361

1721

1.28

4.58

1.4

5.73

5.54

mmol/l

1.78

340

1628

Diabetes, varying definitions

362

1696

1.28

4.55

1.4

1.3

6.67

5.41

mmol/l

23.26

326

1620

Diseases of pulp and periapical tissues, including avohilmo

407

1680

1.26

4.47

1.4

5.69

5.51

mmol/l

1.30

380

1602

Combinations of oral blood glucose lowering drugs

460

0.37

4.43

1.2

7.29

5.89

mmol/l

2.20

435

Cholelithiasis, broad definition with cholecystitis

286

1502

1.31

4.40

1.3

5.87

5.73

mmol/l

1.19

269

1418

Dental caries 2 and operation codes

298

1831

1.29

4.38

1.5

1.4

5.42

5.52

mmol/l

0.54

272

1742

Diabetes mellitus

363

1708

1.27

4.38

1.4

1.3

6.67

5.40

mmol/l

23.40

326

1633

Dental pulpitis 4, only avohilmo

413

1723

1.25

4.34

1.4

5.69

5.53

mmol/l

1.22

383

1642

Biguanides

310

1480

1.29

4.33

1.5

1.3

6.79

5.58

mmol/l

19.77

280

1406

Dependent personality disorder

3.92

4.27

1.1

1.4

5.56

6.42

mmol/l

0.61

Dental pulpitis 1

405

1682

1.25

4.25

1.4

5.69

5.51

mmol/l

1.28

378

1604

Pain in throat and chest

303

1434

1.29

4.25

1.2

1.4

5.87

5.56

mmol/l

4.38

279

1372

Dental pulpitis 4

405

1682

1.25

4.25

1.4

5.69

5.51

mmol/l

1.28

378

1604

Other functional intestinal disorders

136

894

1.45

4.20

1.4

5.79

5.71

mmol/l

0.19

130

841

Dental pulpitis 1, only avohilmo

412

1727

1.25

4.18

1.4

5.70

5.53

mmol/l

1.24

382

1646

Cholecystectomy

221

1463

1.34

4.18

1.4

1.3

5.83

5.78

mmol/l

0.28

207

1374

Asthma, including avohilmo

425

1996

1.24

4.14

1.4

5.64

5.56

mmol/l

0.74

402

1888

Other and unspecified nonorganic psychotic disorders

449

1.65

4.12

1.3

1.4

6.22

5.41

mmol/l

4.24

424

Nerve, nerve root and plexus disorders

359

1794

1.26

4.09

1.4

1.3

5.76

5.66

mmol/l

1.08

334

1701

Cholelithiasis

273

1475

1.30

4.09

1.3

5.88

5.73

mmol/l

1.18

256

1391

Dental caries 2

299

1838

1.28

4.05

1.5

1.4

5.42

5.52

mmol/l

0.57

273

1749

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

131

907

1.45

4.04

1.6

1.4

5.38

5.34

mmol/l

0.17

126

865

Unspecified lump in breast

346

1.74

4.04

1.3

1.4

5.53

5.61

mmol/l

0.35

325

Excluding asthma or asthma-COPD overlap

324

1273

1.28

3.99

1.4

5.63

5.59

mmol/l

0.23

300

1210

Other diseases of jaws

130

2.24

3.99

1.4

5.58

5.57

mmol/l

0.01

124

Ischemic heart diseases

209

972

1.35

3.98

1.2

1.3

6.04

mmol/l

0.02

189

919

Dental caries 2, only avohilmo

294

1817

1.28

3.95

1.5

1.4

5.37

5.52

mmol/l

0.98

269

1727

COPD differential diagnosis

324

1275

1.27

3.95

1.4

1.3

5.64

5.59

mmol/l

0.30

299

1212

Umbilical hernia

517

1.59

3.93

1.4

1.3

5.74

5.79

mmol/l

0.18

492

Disorders of gallbladder, biliary tract and pancreas

320

1630

1.27

3.88

1.3

5.87

5.72

mmol/l

1.44

298

1538

Schizophrenia or delusion

109

737

1.48

3.82

1.3

1.4

6.17

5.58

mmol/l

4.33

100

699

Kela-code for severe mental illness

132

926

1.43

3.82

1.3

1.4

6.26

5.53

mmol/l

4.06

122

878

Other pulmonary diagnosis

322

1273

1.27

3.80

1.4

5.62

5.59

mmol/l

0.17

299

1210

Diseases of oesophagus, stomach and duodenum

365

1783

1.24

3.80

1.3

1.4

5.91

5.61

mmol/l

3.02

349

1680

Presence of cardiac and vascular implants and grafts

100

499

1.52

3.79

1.1

1.2

6.04

6.20

mmol/l

0.89

470

Migraine

210

1349

1.33

3.78

1.4

5.36

5.33

mmol/l

0.12

202

1284

ILD differential diagnosis

322

1274

1.27

3.77

1.4

1.3

5.64

5.59

mmol/l

0.32

297

1211

Migraine, single triptan purchase ok & required. ICD-code if available is included

315

1691

1.26

3.77

1.4

5.39

5.50

mmol/l

0.67

297

1603

Triptan medication for migraine, single purchase ok

315

1691

1.26

3.77

1.4

5.39

5.50

mmol/l

0.67

297

1603

Gastro-oesophageal reflux disease

205

1374

1.32

3.66

1.3

5.94

5.76

mmol/l

0.78

194

1288

Medical observation and evaluation for suspected diseases and conditions

228

887

1.32

3.63

1.3

1.4

5.68

5.55

mmol/l

0.86

210

838

Other sexually transmitted chlamydial diseases

233

0.30

3.58

1.4

1.6

5.09

5.14

mmol/l

—

223

Acute upper respiratory infections

369

1878

1.23

3.55

1.4

5.55

5.61

mmol/l

0.47

348

1775

Diastasis of muscle

6.30

3.52

1.5

1.3

5.21

7.24

mmol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

131

933

1.41

3.52

1.6

1.5

5.38

5.24

mmol/l

0.74

126

894

Diseases of the respiratory system

261

1017

1.29

3.50

1.3

1.4

5.60

5.58

mmol/l

0.09

245

969

Pregnancy with abortive outcome

292

1206

1.27

3.50

1.5

1.4

5.33

5.37

mmol/l

0.31

275

1140

Asthma (only as main-diagnosis), excluding more controls

264

1231

1.28

3.48

1.4

5.61

5.58

mmol/l

0.19

247

1172

Artrosis, including avohilmo

258

1103

1.28

3.47

1.3

5.90

5.77

mmol/l

0.60

236

1045

Hernia of abdominal wall

125

886

1.41

3.45

1.4

1.3

5.97

5.85

mmol/l

0.45

113

828

Asthma (only as main-diagnosis)

266

1263

1.27

3.38

1.4

1.3

5.62

5.59

mmol/l

0.15

249

1201

Asthma, excluding more controls

291

1231

1.26

3.37

1.4

5.62

5.58

mmol/l

0.30

275

1172

Hypothyroidism, other/unspecified

334

1785

1.24

3.37

1.3

1.4

5.64

5.52

mmol/l

0.89

306

1698

Schizophrenia, schizotypal and delusional disorders

107

742

1.44

3.35

1.3

1.4

6.18

5.58

mmol/l

4.18

703

Dentinal caries

418

1.60

3.34

1.3

5.67

5.66

mmol/l

0.01

402

283

1.74

3.34

1.5

1.4

5.32

5.53

mmol/l

0.83

271

Dental caries

502

1.54

3.34

1.3

5.71

5.62

mmol/l

0.15

482

Asthma (mode)

291

1274

1.26

3.28

1.4

1.3

5.59

mmol/l

0.02

275

1211

Exclusions for E4_PCOS_CONSORTIUM

195

1591

0.77

3.27

1.3

1.4

5.62

5.44

mmol/l

1.86

184

1504

Other abnormal products of conception

174

868

1.34

3.27

1.5

1.4

5.16

5.23

mmol/l

0.39

168

829

Sciatica+with lumbago

158

1115

1.35

3.27

1.3

1.4

5.57

5.71

mmol/l

0.97

145

1048

Schizophrenia or delusion, excluding more controls

109

759

1.43

3.21

1.3

1.4

6.17

5.49

mmol/l

5.46

100

721

Other systemic involvement of connective tissue (FG)

566

1.49

3.17

1.3

5.43

5.77

mmol/l

2.57

538

Other acute lower respiratory infections

163

1168

1.33

3.17

1.3

1.4

5.55

5.66

mmol/l

0.56

156

1102

Postmenopausal atrophic vaginitis

275

1.58

3.16

1.3

5.78

5.95

mmol/l

0.87

261

Other diseases of upper respiratory tract

396

1707

1.21

3.16

1.3

1.4

5.65

5.61

mmol/l

0.25

375

1620

Familial hypercholesterolemia, with ischemic heart disease

117

2.14

3.15

1.2

5.90

6.30

mmol/l

0.93

112

Pain in limb

268

1547

1.25

3.14

1.4

5.61

5.55

mmol/l

0.45

247

1466

Bronchitis

374

2028

1.21

3.10

1.4

5.48

5.59

mmol/l

1.10

351

1921

Leiomyoma of uterus

130

1009

0.73

3.04

1.3

5.91

5.67

mmol/l

1.82

122

944

Complications of anaesthesia during pregnancy

10.53

3.02

2.0

1.6

5.04

5.34

mmol/l

—

Diseases of the musculoskeletal system and connective tissue

240

947

1.27

3.01

1.5

1.4

5.49

5.40

mmol/l

0.37

227

901

Varus deformity, not elsewhere classified

4.36

3.01

1.3

5.66

5.75

mmol/l

—

Asthma

292

1263

1.24

3.00

1.4

1.3

5.62

5.59

mmol/l

0.19

276

1201

Meniscus derangement

167

864

1.32

2.98

1.3

6.08

5.91

mmol/l

0.47

154

824

Hypothyreosis and Thyroxine purchase for inclusion criteria

340

1848

1.22

2.96

1.3

1.4

5.63

5.54

mmol/l

0.73

312

1759

Other symptoms and signs involving cognitive functions and awareness

111

744

1.40

2.96

1.2

1.3

5.77

5.95

mmol/l

1.25

102

705

Other benign neoplasms of uterus

2.48

2.96

1.1

1.2

6.03

5.74

mmol/l

0.89

Symptoms and signs involving the skin and subcutaneous tissue

222

1748

1.27

2.95

1.4

5.64

mmol/l

0.03

208

1651

Abnormalities of heart beat

109

771

1.40

2.95

1.3

1.4

5.66

5.62

mmol/l

0.11

100

739

Neurological diseases, wide definition

145

535

1.36

2.95

1.4

1.5

5.42

5.09

mmol/l

3.83

135

518

Wet age-related macular degeneration

187

1.84

2.93

1.3

1.2

6.19

6.26

mmol/l

0.10

175

Other diseases of urinary system

380

1779

1.20

2.91

1.4

5.49

5.56

mmol/l

0.71

360

1686

Type 1 diabetes, definitions combined

223

0.36

2.91

1.8

1.5

7.00

5.15

mmol/l

—

216

Arthrosis

221

953

1.28

2.90

1.3

5.87

5.86

mmol/l

0.06

203

905

Coronary atherosclerosis

160

778

1.33

2.89

1.3

1.2

6.10

6.12

mmol/l

0.10

143

740

Lower leg

6.82

2.88

1.3

1.2

5.68

5.94

mmol/l

—

405

1790

1.20

2.88

1.4

5.59

5.60

mmol/l

0.08

381

1692

Mixed and other personality disorders

192

1.83

2.88

1.2

1.5

5.70

5.49

mmol/l

0.49

184

Diabetic neuropathy

173

0.29

2.81

1.2

1.3

6.28

6.86

mmol/l

—

154

Other spirochaetal diseases

532

0.54

2.81

1.2

1.3

5.69

5.84

mmol/l

0.39

500

Type 1 diabetes, strict (exclude DM2)

221

0.36

2.77

1.7

1.5

7.00

5.15

mmol/l

—

215

Primary gonarthrosis, bilateral

117

747

1.37

2.76

1.3

1.2

6.00

6.12

mmol/l

0.54

107

704

Other female pelvic inflammatory diseases

418

1.54

2.75

1.2

1.4

5.38

5.54

mmol/l

0.78

391

Parodontitis and operation codes

252

1582

1.24

2.75

1.3

5.96

5.77

mmol/l

1.44

234

1494

Cystitis

329

1664

1.21

2.74

1.4

5.46

5.51

mmol/l

0.40

308

1577

Diverticular disease of intestine

185

954

1.29

2.74

1.2

5.94

6.04

mmol/l

0.65

175

893

Hernia of abdominal wall, postoperative

348

1.58

2.72

1.5

1.3

6.00

5.83

mmol/l

0.31

324

Lyme disease

526

0.55

2.72

1.2

1.3

5.69

5.84

mmol/l

0.39

494

Other benign neoplasm of uterus: Corpus uteri

6.11

2.71

1.0

1.1

6.32

5.59

mmol/l

—

Postviral fatigue syndrome

4.30

2.69

1.3

1.6

5.02

5.43

mmol/l

—

Dental caries 3 and operation codes, only avohilmo

114

413

1.39

2.64

1.5

1.4

5.69

5.38

mmol/l

0.80

108

384

Follow-up examination after treatment for conditions other than malignant neoplasms

158

792

1.31

2.62

1.4

5.36

5.49

mmol/l

0.99

149

747

Other disorders of urethra and urinary system

248

1508

1.23

2.60

1.3

1.4

5.61

5.58

mmol/l

0.15

236

1427

Dental caries 1 and operation codes, only avohilmo

327

1.43

2.57

1.4

5.77

5.42

mmol/l

0.73

307

Other noninfective disorders of lymphatic vessels and lymph nodes

2.62

2.53

1.3

5.82

6.23

mmol/l

0.38

Schizophrenia

308

1.59

2.51

1.3

1.4

6.38

5.70

mmol/l

2.35

292

Other diseases of oesophagus

143

1.89

2.50

1.2

1.3

5.76

5.96

mmol/l

1.01

137

Provisional assignment of new diseases of uncertain etiology

157

1219

1.29

2.50

1.5

1.4

5.31

5.49

mmol/l

1.57

148

1156

Codes for special purposes

157

1219

1.29

2.50

1.5

1.4

5.31

5.49

mmol/l

1.57

148

1156

Systemic connective tissue disorders

105

770

1.37

2.49

1.3

5.49

5.76

mmol/l

1.93

100

723

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

128

1651

0.76

2.48

1.5

1.4

5.43

5.49

mmol/l

0.25

119

1562

Exposure to unspecified factor

230

2190

0.81

2.48

1.3

1.4

5.82

5.56

mmol/l

1.40

216

2073

Hypothyroidism (congenital or acquired)

141

614

1.32

2.48

1.3

1.5

5.38

5.00

mmol/l

3.49

129

593

Other congenital malformations of peripheral vascular system

3.85

2.47

1.9

1.4

5.38

6.53

mmol/l

—

Cerebrovascular diseases (FINNGEN)

439

1.42

2.47

1.3

5.87

5.85

mmol/l

0.06

417

Fall on same level

312

2083

0.84

2.46

1.4

5.69

5.55

mmol/l

0.83

293

1972

Inflammatory diseases of female pelvic organs

257

1591

1.22

2.43

1.4

5.39

5.38

mmol/l

0.05

241

1510

Other joint disorders

346

1549

1.19

2.43

1.4

5.55

5.46

mmol/l

0.47

327

1475

Varicose veins

175

1041

1.27

2.42

1.3

1.2

5.77

5.97

mmol/l

1.73

164

973

COPD/asthma/ILD related infections

390

1658

1.18

2.41

1.4

5.64

5.57

mmol/l

0.46

368

1572

COPD/asthma related infections

390

1658

1.18

2.41

1.4

5.64

5.57

mmol/l

0.46

368

1572

Antihypertensive medication - note that there are other indications

263

1180

1.22

2.40

1.4

1.5

5.59

5.14

mmol/l

5.11

252

1126

Hand

6.38

2.38

1.8

1.1

4.92

8.44

mmol/l

—

Glucagon-like peptide-1 (GLP-1) analogues

756

0.68

2.35

1.2

7.49

5.87

mmol/l

4.66

719

Hypothyroidism, strict autoimmune

286

1575

1.20

2.35

1.3

1.4

5.64

5.47

mmol/l

1.69

262

1501

Acetic acid derivatives and related substances

105

399

1.37

2.34

1.3

1.4

5.74

5.38

mmol/l

0.83

381

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

318

1819

1.19

2.30

1.3

1.4

5.78

5.60

mmol/l

1.93

296

1723

Medical abortion

266

1194

1.21

2.29

1.4

5.35

5.38

mmol/l

0.19

250

1128

Other benign neoplasm of uterus: Corpus uteri

4.70

2.28

1.0

1.2

6.32

5.57

mmol/l

—

Hypothyroidism, levothyroxine purchases

139

614

1.30

2.26

1.4

1.5

5.38

5.00

mmol/l

3.43

128

593

Hypothyroidism and >3 levothyroxin purchases

139

614

1.30

2.26

1.4

1.5

5.38

5.00

mmol/l

3.43

128

593

Complications following infusion, transfusion and therapeutic injection

3.92

2.26

1.4

1.2

5.28

7.33

mmol/l

—

Enthesopathies of lower limb, excluding foot

456

1.45

2.23

1.3

5.62

5.76

mmol/l

0.63

433

Cardiovascular diseases

272

1232

1.20

2.20

1.4

1.5

5.37

5.26

mmol/l

0.91

261

1172

Other systemic involvement of connective tissue

618

1.38

2.17

1.3

5.43

5.74

mmol/l

2.39

582

Diabetes medication

338

1750

1.17

2.12

1.5

1.3

6.68

5.44

mmol/l

21.09

306

1669

Hypothyroidism, strict autoimmune, 3 medication purchases required

309

1786

1.18

2.11

1.3

1.4

5.66

5.52

mmol/l

1.37

284

1698

Poisoning by medicine, drug-induced

3.23

2.10

1.4

1.3

6.03

6.67

mmol/l

—

Unspecified mental disorder

136

1065

1.28

2.09

1.3

1.4

6.21

5.49

mmol/l

4.15

126

1009

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

333

0.52

2.08

1.4

5.38

5.57

mmol/l

0.40

315

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

3.53

2.06

1.6

1.4

6.16

6.94

mmol/l

—

Allergic conjunctivitis

139

1727

0.79

2.05

1.5

1.4

5.46

5.48

mmol/l

0.09

130

1635

Any event in cancer register

238

1692

0.83

2.03

1.3

1.4

5.80

5.61

mmol/l

1.99

227

1593

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

282

1456

1.18

1.97

1.4

1.3

7.06

5.51

mmol/l

20.93

254

1390

Autoimmune diseases excluding thyroid diseases

273

1788

0.85

1.94

1.4

5.89

5.53

mmol/l

2.05

254

1702

Amenorrhoea

309

0.52

1.94

1.5

1.6

5.21

5.01

mmol/l

0.48

301

Asthma, hospital admissions , main diagnosis only

271

2057

1.18

1.94

1.4

5.62

5.56

mmol/l

0.42

254

1949

Convergence insufficiency and excess

2.76

1.94

2.1

1.4

4.88

5.22

mmol/l

—

Parodontitis

260

1618

1.19

1.91

1.3

5.95

5.76

mmol/l

1.62

242

1527

Injury, poisoning and certain other consequences of external causes

230

957

1.21

1.91

1.4

5.61

5.48

mmol/l

0.57

219

900

Other arthrosis

136

768

1.27

1.91

1.3

1.2

5.89

6.00

mmol/l

0.73

128

731

Acute upper respiratory infections of multiple and unspecified sites

258

1633

1.18

1.89

1.4

5.37

5.55

mmol/l

1.99

240

1550

Parodontitis or operation codes

260

1619

1.18

1.88

1.3

5.95

5.76

mmol/l

1.62

242

1528

323

1.46

1.85

1.3

1.2

6.07

6.26

mmol/l

0.48

302

Acute bronchitis

114

871

1.28

1.85

1.3

1.4

5.55

5.70

mmol/l

0.91

109

819

Acute nasopharyngitis (common cold)

204

1.61

1.84

1.2

1.4

5.54

5.76

mmol/l

0.56

196

Coxibs

100

403

1.32

1.84

1.3

1.4

5.57

5.37

mmol/l

1.18

385

Chronic periodontitis, including avohilmo

258

1619

1.18

1.82

1.3

5.95

5.76

mmol/l

1.60

241

1527

Explicit bacterial Sepsis

166

0.42

1.78

1.6

1.4

5.94

5.83

mmol/l

—

160

Rheumatoid arthritis, including avohilmo

863

0.73

1.75

1.3

5.71

5.84

mmol/l

0.35

816

Diseases of the skin and subcutaneous tissue

375

1640

1.15

1.75

1.4

5.58

5.57

mmol/l

0.05

356

1553

Disturbances of skin sensation

740

1.30

1.73

1.4

5.48

5.54

mmol/l

0.26

703

Other/unspecified dorsalgia

110

859

1.28

1.72

1.4

5.75

5.64

mmol/l

0.50

104

812

Ankle and foot

3.89

1.72

1.8

1.2

5.54

7.54

mmol/l

—

Other and unspecified tonsillitis

138

943

1.24

1.71

1.5

5.41

5.28

mmol/l

0.46

131

906

Previous suicide attempt

3.19

1.67

1.2

1.3

5.33

6.89

mmol/l

—

Other disorders of eyelid

100

753

1.28

1.66

1.4

1.3

5.94

5.99

mmol/l

0.15

704

Soft tissue disorders related to use, overuse and pressure

502

1.36

1.66

1.2

1.3

5.91

5.95

mmol/l

0.11

471

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

151

613

1.24

1.65

1.4

5.54

5.39

mmol/l

0.97

144

591

Cervicobrachial syndrome

477

1.36

1.65

1.3

5.63

5.75

mmol/l

0.42

451

Polycystic ovarian syndrome, consortium definition

298

1555

1.16

1.63

1.4

5.70

5.32

mmol/l

6.99

277

1479

Gout due to impairment of renal function

3.61

1.62

1.0

1.2

6.02

7.77

mmol/l

—

Melanoma in situ of trunk

3.60

1.62

1.6

1.1

5.94

7.66

mmol/l

—

Chronic lower respiratory diseases

416

1990

1.13

1.62

1.4

5.62

5.56

mmol/l

0.56

393

1883

Postmenopausal bleeding

264

1.38

1.60

1.2

1.3

5.98

5.99

mmol/l

0.02

250

Parapsoriasis

2.52

1.60

1.3

1.4

6.00

6.31

mmol/l

—

Used for control exclusion in common control thyroid runs

381

1699

1.14

1.60

1.4

5.75

5.50

mmol/l

1.83

356

1620

Fissure and fistula of anal and rectal regions

497

1.35

1.60

1.5

1.3

5.83

mmol/l

0.02

468

Other diseases of intestines

367

1875

1.14

1.59

1.3

1.4

5.69

5.53

mmol/l

1.42

349

1776

Family history of other conditions

2.72

1.58

1.1

1.5

6.04

6.03

mmol/l

—

Assault by blunt object

3.02

1.58

1.0

1.3

5.68

6.77

mmol/l

—

Benign neoplasm: Other and unspecified parts of small intestine

3.02

1.58

1.3

1.1

5.97

6.97

mmol/l

—

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

749

0.78

1.58

1.2

1.3

5.83

5.77

mmol/l

0.19

707

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

749

0.78

1.58

1.2

1.3

5.83

5.77

mmol/l

0.19

707

Disorders of breast

174

1346

1.20

1.56

1.4

5.44

5.51

mmol/l

0.38

164

1272

Gout

330

1.41

1.56

1.1

1.2

6.29

6.25

mmol/l

0.08

311

Hernia

267

1564

1.16

1.54

1.3

5.88

5.74

mmol/l

1.03

250

1473

Symptoms and signs involving the nervous and musculoskeletal systems

163

1357

1.20

1.52

1.4

5.80

5.68

mmol/l

0.72

142

1289

Traumatic subarachnoid haemorrhage

0.00

1.52

0.0

1.2

—

6.67

—

Excessive vomiting in pregnancy

217

1.53

1.51

1.4

5.50

5.15

mmol/l

0.28

204

Chronic diseases of tonsils and adenoids

286

1573

1.15

1.51

1.4

5.42

5.55

mmol/l

1.21

266

1493

Finngen Rheumatological endpoints

338

1692

1.14

1.51

1.3

1.4

5.62

5.55

mmol/l

0.62

316

1611

Tonsillectomy and adenotomy

222

1320

1.17

1.50

1.5

1.4

5.31

5.33

mmol/l

0.04

208

1261

Gout, idiopatic and unspecified

316

1.43

1.49

1.1

1.2

6.32

6.21

mmol/l

0.22

298

Excessive, frequent and irregular menstruation

193

904

1.19

1.49

1.4

1.5

5.48

5.21

mmol/l

2.91

179

872

Diabetes, insulin treatment (Kela reimbursement)

292

1556

1.15

1.48

1.4

1.3

7.07

5.55

mmol/l

21.06

262

1476

Dental caries 2 and operation codes, only avohilmo

255

1366

1.16

1.48

1.4

5.46

5.53

mmol/l

0.37

232

1285

Other puerperal infections

301

1.43

1.46

1.8

1.5

4.90

5.10

mmol/l

1.25

287

Cardiovascular diseases (excluding rheumatic etc)

257

1282

1.16

1.46

1.4

5.56

5.31

mmol/l

2.94

246

1220

Assault by other specified means

3.15

1.44

1.2

1.4

5.92

6.67

mmol/l

—

Benign neoplasm: Other and unspecified parts of small intestine

2.75

1.44

1.3

1.2

5.97

6.89

mmol/l

—

Autoimmune diseases excluding thyroid diseases, strict definition

273

1744

0.87

1.42

1.4

5.88

5.51

mmol/l

2.11

254

1665

Tramadol

245

1362

1.16

1.41

1.3

5.79

5.70

mmol/l

0.76

226

1286

Bacterial infection, other or unspecified

122

898

1.23

1.40

1.2

1.3

6.17

5.84

mmol/l

1.54

111

845

Recurrent or chronic depression

164

993

1.19

1.40

1.3

1.4

5.70

5.41

mmol/l

1.34

155

946

Streptococcal septicaemia

136

0.44

1.40

1.3

1.4

6.05

5.97

mmol/l

—

130

Spirochaetal infections, other/unspecified

137

0.44

1.40

1.2

1.3

5.19

5.94

mmol/l

—

130

Female genital prolapse

417

1.28

1.39

1.3

1.4

5.91

5.65

mmol/l

0.64

397

Premature separation of placenta [abruptio placentae]

2.09

1.39

1.7

1.5

4.77

5.55

mmol/l

2.93

Disorders of synovium and tendon

159

1204

1.19

1.36

1.3

1.4

5.62

5.67

mmol/l

0.29

153

1137

Ulcer of lower limb, not elsewhere classified

197

0.51

1.36

1.1

1.3

7.20

6.06

mmol/l

—

184

Lung diseases due to external agents

197

0.51

1.36

1.2

1.3

5.81

6.08

mmol/l

—

187

Cardiac arrhythmias

204

1154

1.17

1.36

1.3

1.4

5.62

5.37

mmol/l

2.88

195

1109

Chronic suppurative otitis media, including avohilmo

135

1.63

1.35

1.3

1.4

6.28

5.77

mmol/l

0.69

129

Arthropathies

344

1551

1.13

1.35

1.4

5.49

5.46

mmol/l

0.11

320

1476

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

143

1.61

1.35

1.3

1.4

5.96

5.84

mmol/l

0.17

135

Gout, FINNGEN

374

1.37

1.35

1.1

1.2

6.29

6.25

mmol/l

0.07

351

Contact with sharp object, undetermined intent

0.00

1.34

0.0

1.5

—

6.23

—

Triptan medication for migraine, min. 3 purchases

228

1558

1.16

1.34

1.4

5.37

5.38

mmol/l

0.02

215

1484

Anxiety (asthma-related co-morbidities)

218

1486

1.16

1.31

1.5

1.4

5.63

5.40

mmol/l

1.33

211

1410

Diseases of the ear and mastoid process

414

1880

1.11

1.31

1.4

5.56

5.55

mmol/l

0.08

391

1781

Other enthesopathies

656

1.27

1.31

1.4

1.3

5.87

5.83

mmol/l

0.12

622

Postprocedural disorders of nervous system

193

0.52

1.29

1.5

4.83

5.42

mmol/l

—

187

Melanoma in situ of trunk

2.80

1.29

1.6

1.2

5.94

7.38

mmol/l

—

Nonalcoholic fatty liver disease

153

1.57

1.28

1.4

5.64

5.88

mmol/l

0.50

146

Pleural plaque

132

0.45

1.28

1.3

1.2

5.77

6.37

mmol/l

—

126

Asthma/COPD (KELA code 203)

317

1984

1.13

1.27

1.4

5.63

5.57

mmol/l

0.59

301

1877

Disorders of choroid and retina

143

1237

0.84

1.26

1.2

1.3

6.03

5.89

mmol/l

0.61

136

1157

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

110

1334

0.82

1.25

1.3

5.92

5.75

mmol/l

0.53

103

1253

Chronic suppurative otitis media

107

1.69

1.25

1.3

1.4

6.03

5.94

mmol/l

0.08

102

Other symptoms and signs involving the nervous and musculoskeletal systems

124

1030

1.20

1.25

1.4

5.72

5.64

mmol/l

0.39

107

982

Nonspecific lymphadenitis

115

1.66

1.24

1.2

1.4

5.65

5.83

mmol/l

0.19

110

Cough

108

850

1.22

1.23

1.3

1.4

5.69

mmol/l

0.00

811

Other lack of coordination

2.64

1.22

2.0

1.1

6.20

7.26

mmol/l

—

Other specific joint derangements/joint disorders

260

1535

1.14

1.21

1.4

5.60

5.46

mmol/l

1.35

246

1463

Malignant neoplasm of breast

849

0.81

1.19

1.2

1.3

5.88

5.81

mmol/l

0.28

795

Disorders of vestibular function (Vertigo)

111

911

1.21

1.19

1.3

5.79

5.88

mmol/l

0.56

105

865

Hallux rigidus

250

0.60

1.18

1.1

1.2

6.29

6.10

mmol/l

0.34

237

Benign neoplasm: Connective and other soft tissue, unspecified

2.52

1.15

1.2

5.71

6.84

mmol/l

—

Diseases of inner ear

129

1063

1.19

1.15

1.3

5.80

5.89

mmol/l

0.60

120

1000

Diseases of the eye and adnexa

332

1489

1.12

1.14

1.4

5.57

5.47

mmol/l

0.47

315

1410

Diseases of middle ear and mastoid

205

1466

1.15

1.13

1.4

5.25

5.39

mmol/l

1.21

194

1391

Macular pucker

234

0.60

1.13

1.1

1.2

5.65

6.21

mmol/l

2.06

217

Hyperaldosteronism

2.01

1.12

1.3

5.97

6.41

mmol/l

—

Reimbursement for rheumatic diseases

122

1443

0.84

1.11

1.3

1.4

5.51

5.72

mmol/l

1.29

114

1359

Localized swelling, mass and lump of skin and subcutaneous tissue

681

1.23

1.10

1.3

5.83

5.79

mmol/l

0.15

643

Other chronic obstructive pulmonary disease, including avohilmo

107

738

1.21

1.10

1.3

1.2

6.09

6.10

mmol/l

0.04

101

692

Foreign body in ear

2.27

1.10

1.9

1.4

5.40

6.37

mmol/l

—

Trochanteric bursitis

234

1.41

1.10

1.2

1.3

5.87

6.04

mmol/l

0.29

219

Malignant neoplasm of breast, HER2-negative

823

0.82

1.09

1.2

1.3

5.92

5.83

mmol/l

0.38

769

Synovial hypertrophy, not elsewhere classified

2.40

1.09

1.0

1.4

5.30

6.73

mmol/l

—

HSIL lesion of the vagina

2.40

1.09

1.2

1.4

5.34

5.40

mmol/l

—

Fall on same level involving ice and snow

157

1352

1.16

1.08

1.2

1.4

5.82

5.68

mmol/l

0.88

149

1279

Implicit Sepsis

184

1244

1.15

1.07

1.2

1.3

5.87

5.78

mmol/l

0.47

168

1173

Benign neoplasm: Transverse colon

166

0.54

1.07

1.6

1.3

5.67

6.12

mmol/l

—

155

Menorrhagia

144

679

1.17

1.05

1.4

5.59

5.36

mmol/l

2.34

138

652

Other bursopathies

203

1.43

1.05

1.3

5.75

6.03

mmol/l

0.74

193

Other heart diseases

145

819

1.17

1.04

1.3

1.4

5.70

5.57

mmol/l

0.88

139

779

Thyroiditis, ILD-related definition

297

1.35

1.04

1.3

1.4

5.21

5.49

mmol/l

0.97

284

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

270

1570

1.12

1.03

1.3

5.76

5.79

mmol/l

0.13

255

1475

Burn and corrosion of ankle and foot

2.29

1.03

1.2

5.15

6.88

mmol/l

—

Guttate psoriasis

2.28

1.03

1.2

1.4

5.46

6.47

mmol/l

—

Abnormal weight loss

138

1.53

1.02

1.5

1.3

5.38

5.93

mmol/l

1.34

132

Unspecified haematuria

573

1.23

1.02

1.2

1.3

6.00

5.99

mmol/l

0.04

534

Hepatic failure, not elsewhere classified

1.92

1.02

1.1

1.2

6.10

6.46

mmol/l

—

Renal tubulo-interstitial diseases

209

1813

0.88

1.02

1.3

1.4

5.94

5.59

mmol/l

1.96

197

1713

Injury of muscle and tendon at shoulder and upper arm level

608

1.23

1.01

1.2

1.3

6.02

6.05

mmol/l

0.09

569

Cervicalgia

412

1.29

1.01

1.2

1.3

5.69

5.79

mmol/l

0.32

388

All anxiety disorders

223

1591

1.13

1.01

1.5

1.4

5.62

5.41

mmol/l

1.26

216

1506

Benign neoplasm: Duodenum

2.01

1.00

1.7

1.2

6.13

6.56

mmol/l

—

Asthma (diagnoses ohter than nonallergic)

269

2064

1.11

1.00

1.3

1.4

5.60

5.58

mmol/l

0.19

255

1953

Dentofacial anomalies [including malocclusion]

728

1.21

0.99

1.4

5.38

5.43

mmol/l

0.25

704

Opioids

366

1747

1.10

0.99

1.4

5.68

5.49

mmol/l

2.69

345

1655

Other retinal disorders

102

975

0.84

0.99

1.3

6.08

5.93

mmol/l

0.47

917

Benign neoplasm: Connective and other soft tissue, unspecified

2.19

0.98

1.2

5.71

6.85

mmol/l

—

Polyarteritis nodosa and related conditions

2.19

0.98

1.4

1.3

5.24

6.70

mmol/l

—

Presence of other functional implants

690

0.82

0.98

1.2

1.3

6.10

6.11

mmol/l

0.01

648

Any reimbursement code in KELA

257

1149

1.12

0.98

1.4

5.67

5.17

mmol/l

3.79

243

1105

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

0.00

0.97

0.0

1.3

—

6.80

—

Asthma, unspecified (mode), excluding more controls

156

1063

1.15

0.97

1.2

1.3

5.72

5.65

mmol/l

0.50

143

1010

Carcinoma in situ of other and unspecified digestive organs

0.00

0.96

0.0

1.2

—

6.78

—

Carcinoma in situ of other and unspecified digestive organs

0.00

0.96

0.0

1.2

—

6.78

—

Erectile dysfunction

108

1.58

0.96

1.2

6.22

6.37

mmol/l

0.23

102

Anxiety disorders

303

1942

1.11

0.96

1.4

5.67

5.53

mmol/l

0.86

285

1837

Malignant neoplasm

211

1411

0.89

0.96

1.2

1.3

5.91

5.78

mmol/l

1.05

202

1321

Malignant neoplasm of colon

223

0.63

0.96

1.1

1.3

6.21

6.14

mmol/l

0.10

211

Conjunctivitis

203

1993

0.89

0.95

1.5

1.4

5.42

5.52

mmol/l

0.59

192

1886

Chronic mastoiditis

0.00

0.95

0.0

1.3

—

6.63

—

Other, unspecified and serous retinal detachments

1.90

0.94

1.4

1.2

5.89

6.48

mmol/l

—

Dermatitis due to substances taken internally

117

0.51

0.94

1.2

1.5

5.22

5.77

mmol/l

—

112

Duodenal ulcer

144

0.55

0.93

1.1

1.2

7.33

6.03

mmol/l

—

134

Diagnoses used for exclusion with ILD

431

0.74

0.92

1.3

6.00

5.98

mmol/l

0.04

409

Other specified/unspecified spondylopathies

2.15

0.91

1.0

1.3

5.25

6.74

mmol/l

—

Unspecified privation

195

0.61

0.90

1.7

1.4

5.05

5.78

mmol/l

3.10

186

Melanocytic naevi, other sites/unspecified

151

1.46

0.90

1.3

1.4

5.47

5.77

mmol/l

0.57

146

Injuries to the head

298

2136

0.91

0.90

1.3

1.4

5.62

5.57

mmol/l

0.30

277

2024

L04AA Selective immunosuppressants

473

0.76

0.88

1.4

1.3

5.87

5.73

mmol/l

0.17

448

Benign neoplasm: Transverse colon

152

0.59

0.88

1.6

1.3

5.67

6.18

mmol/l

—

141

Implicit bacterial Sepsis

559

1.21

0.88

1.2

1.3

6.06

6.03

mmol/l

0.07

525

Endometriosis

117

810

0.86

0.87

1.4

1.5

5.44

5.25

mmol/l

1.76

107

781

Other and unspecified diseases of blood and blood-forming organs

2.01

0.87

1.2

1.1

6.20

6.81

mmol/l

—

Malignant neoplasm of liver and intrahepatic bile ducts

2.01

0.87

1.0

1.2

7.37

6.86

mmol/l

—

Other and unspecified disorders of vitreous body

736

1.19

0.86

1.2

1.3

5.92

6.04

mmol/l

0.69

688

Condition for Implicit Sepsis (Organ dysfunction codes)

232

1515

1.11

0.85

1.2

1.4

5.82

5.73

mmol/l

0.59

211

1433

Abrasion of teeth

496

1.20

0.85

1.3

1.4

5.92

5.58

mmol/l

0.55

473

Acute tubulo-interstitial nephritis

142

1437

0.88

0.85

1.3

1.4

5.81

5.57

mmol/l

0.90

134

1360

Vitamin D deficiency

1.94

0.84

1.8

1.4

5.50

6.21

mmol/l

—

Superficial injury of thorax

291

1.31

0.84

1.5

1.3

5.79

5.69

mmol/l

0.17

277

Inguinal hernia

131

766

1.15

0.84

1.2

1.3

5.88

5.86

mmol/l

0.03

123

724

Melanocytic naevi, other sites/unspecified

154

1.43

0.83

1.3

1.4

5.47

5.79

mmol/l

0.63

149

External causes of morbidity and mortality

270

1225

1.10

0.83

1.4

5.68

5.48

mmol/l

1.16

257

1154

Papulosquamous disorders

100

854

1.17

0.83

1.3

5.78

5.82

mmol/l

0.15

806

Asthma, unspecified (mode)

156

1089

1.14

0.83

1.2

1.3

5.72

5.66

mmol/l

0.39

143

1033

Neurotic, stress-related and somatoform disorders

298

1933

1.10

0.82

1.4

5.67

5.53

mmol/l

0.89

281

1828

Asthma-related infections

160

1391

1.13

0.82

1.3

1.4

5.58

5.62

mmol/l

0.22

153

1317

Asthma, hospital admission 2, infections

160

1391

1.13

0.82

1.3

1.4

5.58

5.62

mmol/l

0.22

153

1317

Peritonsillar abscess

579

1.21

0.82

1.2

1.5

5.63

5.40

mmol/l

0.31

553

Infective bursitis

1.88

0.82

1.3

1.2

5.55

6.78

mmol/l

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

271

1.26

0.81

1.3

1.2

6.17

6.04

mmol/l

0.37

260

Keratitis

800

1.18

0.81

1.3

1.4

5.64

5.71

mmol/l

0.17

756

Thyrotoxicosis with toxic multinodular goitre

1.58

0.81

1.4

6.05

5.98

mmol/l

0.04

Oral corticosteroids

342

1901

1.09

0.80

1.3

1.4

5.71

5.61

mmol/l

0.79

319

1802

Second line medication for Crohn's disease

126

1441

0.87

0.80

1.4

5.47

5.69

mmol/l

1.29

117

1358

Other or unspecified ileus, impaction or obstruction

271

0.70

0.80

1.3

6.22

6.10

mmol/l

0.15

255

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.2

—

5.97

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.00

0.79

0.0

1.2

—

6.76

—

Viral encephalitis, not elsewhere classified/unspecified

0.00

0.79

0.0

1.2

—

6.77

—

Benign lipomatous neoplasm of other sites/unspecified

131

1.45

0.78

1.1

1.3

6.17

6.06

mmol/l

0.18

125

Somnolence

0.00

0.77

0.0

1.4

—

6.38

—

Exposure to other and unspecified man-made environmental factors

0.00

0.77

0.0

1.4

—

6.44

—

Accidents

320

1470

1.09

0.77

1.4

5.65

5.53

mmol/l

0.70

302

1386

Congenital malformations of the circulatory system

283

0.72

0.77

1.5

1.4

5.19

5.64

mmol/l

1.56

269

Benign neoplasm: Adrenal gland

115

1.48

0.76

1.1

1.3

6.40

6.17

mmol/l

0.19

110

Other and unspecified epidermal thickening

1.77

0.76

1.3

1.4

5.28

6.36

mmol/l

—

Human immunodeficiency virus [HIV] disease

0.00

0.76

0.0

1.2

—

6.60

—

Visual disturbances

126

1105

1.14

0.75

1.4

5.63

5.69

mmol/l

0.13

121

1044

Disorders of eyelid, lacrimal system and orbit

236

1681

1.10

0.75

1.3

5.76

5.71

mmol/l

0.16

224

1586

Type 2 diabetes, wide definition

183

1067

1.12

0.75

1.3

6.86

5.67

mmol/l

14.22

165

1014

Psychiatric diseases

371

1718

1.08

0.74

1.4

5.79

5.54

mmol/l

2.64

350

1623

Disorders of conjunctiva

222

2047

0.91

0.74

1.5

1.4

5.45

5.54

mmol/l

0.57

210

1938

Congenital malformations of heart and great arteries

236

0.70

0.74

1.4

5.35

5.62

mmol/l

0.47

228

Other specified and unspecified personality disorders

227

1.32

0.74

1.2

1.5

5.65

5.49

mmol/l

0.41

218

Coronary angioplasty

435

1.20

0.74

1.2

6.26

6.16

mmol/l

0.30

414

Depression or dysthymia

232

1177

1.10

0.74

1.4

5.71

5.53

mmol/l

1.86

220

1115

Keratoconus

1.85

0.73

1.4

6.32

6.34

mmol/l

—

Other disorders of binocular movement

1.64

0.73

2.1

1.4

4.88

5.80

mmol/l

—

Malignant melanoma of skin

184

0.65

0.73

1.2

1.3

5.95

6.07

mmol/l

0.23

175

Lesion of ulnar nerve

245

1.31

0.73

1.3

5.65

5.91

mmol/l

0.83

239

Other noninfective gastroenteritis and colitis

524

0.80

0.73

1.3

1.4

5.52

5.68

mmol/l

0.40

496

Haemorrhage from respiratory passages

503

1.20

0.72

1.2

1.3

6.11

5.91

mmol/l

0.63

480

Injuries to the knee and lower leg

384

2041

1.08

0.72

1.4

5.67

5.56

mmol/l

0.99

362

1930

Other congenital malformations of ear

1.76

0.71

2.0

1.6

5.06

mmol/l

—

Non-follicular lymphoma, hilmo, excluding all cancers

134

1.42

0.71

1.4

1.3

6.02

6.16

mmol/l

0.20

127

Other and unspecified vascular occlusions

134

1.42

0.71

1.3

1.2

6.56

6.23

mmol/l

0.22

125

Malignant neoplasm of other connective and soft tissue

1.93

0.70

1.6

1.2

6.04

6.84

mmol/l

—

Use of levodopa decarboxylase inhibitor

182

0.66

0.70

1.2

5.80

6.19

mmol/l

0.85

172

Diarrhoea and gastroenteritis of presumed infectious origin

212

1750

1.10

0.70

1.4

5.64

5.54

mmol/l

0.42

196

1667

Enteropathic arthropathies

1.71

0.70

1.6

1.3

5.14

5.75

mmol/l

—

Superficial injuries involving multiple body regions

1.71

0.70

1.1

1.4

6.94

6.21

mmol/l

—

MS-disease / Multiple Sclerosis

181

0.66

0.69

1.3

1.5

5.61

5.50

mmol/l

0.11

174

Oral lichen ruber planus wide, hypothyreosis or thyroxin

1.53

0.69

1.2

1.4

5.91

6.03

mmol/l

0.12

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

128

1438

0.89

0.69

1.3

1.4

5.94

5.73

mmol/l

0.86

119

1353

Disorders of vitreous body

103

879

1.15

0.69

1.2

1.3

6.08

6.00

mmol/l

0.25

823

Injuries involving multiple body regions

1.64

0.68

1.2

1.4

6.40

6.04

mmol/l

—

Paraplegia, diplegia of upper limbs

1.86

0.68

1.6

1.2

5.29

6.79

mmol/l

—

Other and unspecified effects of external causes

731

1.16

0.68

1.3

1.5

5.45

5.46

mmol/l

0.01

690

Erythema intertrigo

1.86

0.68

1.0

1.2

5.28

6.78

mmol/l

—

Pedestrian injured in collision with car, pick-up truck or van

1.67

0.68

1.3

1.5

5.40

6.26

mmol/l

—

Disorders of vitreous body and globe

106

904

1.14

0.68

1.2

1.3

6.06

6.00

mmol/l

0.17

847

Haemorrhoids and perianal venous thrombosis

519

1.19

0.67

1.2

1.3

6.02

5.95

mmol/l

0.14

491

Anxiety disorders, excluding more controls

273

1665

1.09

0.67

1.4

5.74

5.52

mmol/l

1.60

256

1576

Bronchitis, not specified as acute or chronic

136

1.40

0.66

1.4

5.70

5.96

mmol/l

0.52

131

Other specific arthropathies, wide

1.79

0.66

1.0

1.3

5.50

6.65

mmol/l

—

Fracture of rib(s), sternum and thoracic spine

495

0.81

0.66

1.1

1.3

6.66

5.93

mmol/l

0.63

469

Other antidepressants

342

1658

1.08

0.64

1.3

1.4

5.85

5.52

mmol/l

3.71

321

1580

Colonic or urogenital fistula

578

1.18

0.64

1.5

1.3

5.83

5.79

mmol/l

0.12

551

Acute nephritic syndrome

1.73

0.64

2.2

1.2

5.36

6.61

mmol/l

—

Other arrhythmias

185

1286

1.10

0.63

1.2

1.4

5.67

5.73

mmol/l

0.26

170

1219

Any mental disorder

372

1738

1.07

0.63

1.4

5.80

5.55

mmol/l

2.74

349

1644

Hard cardiovascular diseases

176

1022

1.11

0.63

1.2

1.3

6.02

6.00

mmol/l

0.06

158

967

Non-follicular lymphoma

138

1.38

0.62

1.4

1.3

6.02

6.16

mmol/l

0.21

132

Benign neoplasm: Adrenal gland

121

1.41

0.62

1.1

1.3

6.40

6.15

mmol/l

0.21

116

Orchitis and epididymitis

104

0.58

0.61

1.3

5.75

6.52

mmol/l

—

Other misadventures during surgical and medical care

1.67

0.61

1.4

1.2

5.72

6.55

mmol/l

—

Collagenous colitis

164

0.67

0.61

1.2

1.4

5.64

5.80

mmol/l

0.22

156

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

0.00

0.60

0.0

1.4

—

7.03

—

Scleritis

0.00

0.60

0.0

1.2

—

5.84

—

Other and unspecified haemorrhagic conditions

0.00

0.60

0.0

1.3

—

7.00

—

Melanoma in situ

1.57

0.60

1.5

1.2

5.64

6.42

mmol/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

1.57

0.60

1.1

6.95

6.49

mmol/l

—

Iliotibial band syndrome

0.00

0.60

0.0

1.6

—

5.87

—

Other protozoal intestinal diseases

0.00

0.60

0.0

1.6

—

6.46

—

Pneumocystosis

0.00

0.60

0.0

1.1

—

7.01

—

Hereditary retinal dystrophy

0.00

0.60

0.0

1.4

—

6.70

—

Restless leg syndrome

227

1.28

0.59

1.3

5.37

5.88

mmol/l

1.92

216

Benign neoplasm: Skin of ear and external auricular canal

1.54

0.59

1.6

1.3

5.97

6.25

mmol/l

—

Other heart diseases, wide

293

1688

1.08

0.59

1.3

1.4

5.71

5.62

mmol/l

0.70

275

1604

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

221

1421

0.92

0.59

1.2

1.3

5.88

5.75

mmol/l

1.08

210

1337

Diseases of the myoneural junction and muscle

183

1.31

0.59

1.2

1.3

5.86

5.97

mmol/l

0.17

175

Malignant neoplasm, wide definition for exclusion

221

1421

0.92

0.59

1.2

1.3

5.88

5.75

mmol/l

1.08

210

1337

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

221

1421

0.92

0.59

1.2

1.3

5.88

5.75

mmol/l

1.08

210

1337

Unspecified abortion

1.45

0.59

1.3

5.83

5.54

mmol/l

0.60

Other necrotizing vasculopathies

1.45

0.59

1.1

1.3

5.77

6.17

mmol/l

0.69

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

0.00

0.58

0.0

1.3

—

6.58

—

Carcinoma in situ of breast, other/unspecified

0.00

0.58

0.0

1.2

—

5.86

—

Malignant neoplasm of tongue

0.00

0.58

0.0

1.2

—

7.14

—

Failed attempted abortion

1.72

0.58

1.3

1.4

4.82

5.10

mmol/l

—

Pain, not elsewhere classified

650

1.15

0.58

1.4

5.68

5.64

mmol/l

0.14

617

Visual disturbances and blindness

130

1169

1.11

0.57

1.4

5.72

5.69

mmol/l

0.06

124

1105

Other peripheral vascular diseases

161

0.68

0.57

1.6

1.3

5.33

5.81

mmol/l

0.94

153

Any gastric operation

319

1493

1.07

0.57

1.4

5.67

5.44

mmol/l

1.51

304

1418

GASTRO-related operations

319

1493

1.07

0.57

1.4

5.67

5.44

mmol/l

1.51

304

1418

Venous complications and haemorrhoids in pregnancy

1.67

0.56

1.3

1.4

5.18

5.08

mmol/l

—

Benign neoplasm: Anus and anal canal

1.67

0.56

1.0

1.3

5.42

6.58

mmol/l

—

Other specified disorders of muscle

1.67

0.56

1.5

1.4

5.65

6.48

mmol/l

—

Benign neoplasm: Anus and anal canal

1.67

0.56

1.0

1.2

5.42

6.57

mmol/l

—

Coxarthrosis

105

631

1.13

0.56

1.2

6.01

6.09

mmol/l

0.43

599

Benign lipomatous neoplasm of other sites/unspecified

141

1.35

0.56

1.1

1.3

6.17

6.10

mmol/l

0.13

135

Complications of procedures, not elsewhere classified

230

1838

1.08

0.55

1.3

5.72

5.67

mmol/l

0.22

219

1732

Hyperprolactinaemia

1.45

0.55

1.5

5.55

5.61

mmol/l

0.07

Obsessive-compulsive disorder

217

0.74

0.55

1.1

1.6

5.57

5.17

mmol/l

0.80

210

Symptoms and signs involving cognition, perception, emotional state and behaviour

281

1835

1.07

0.55

1.3

1.4

5.71

5.67

mmol/l

0.24

256

1742

Psoriasis (vulgaris), strict definition

1.58

0.54

1.7

1.3

5.60

6.40

mmol/l

—

Other external causes of accidental injury

314

1470

1.07

0.54

1.4

5.62

5.53

mmol/l

0.47

298

1386

Colon adenocarcinoma

170

0.71

0.53

1.2

6.47

6.22

mmol/l

0.55

160

L04AX Other immunosuppressants

126

1393

0.90

0.53

1.4

5.47

5.71

mmol/l

1.45

117

1311

Mental and behavioural disorders due to alcohol, excluding acute intoxication

101

900

1.12

0.52

1.3

6.02

5.81

mmol/l

0.88

851

Alcohol use disorder, ICD-based

835

1.13

0.52

1.3

6.00

5.79

mmol/l

0.77

791

Inflammatory diseases of the central nervous system

146

0.68

0.52

1.1

1.4

5.54

5.83

mmol/l

—

139

Oter anti-inflammatory and antirheumatic agents, non-steroids

208

1.20

0.52

1.3

5.87

5.95

mmol/l

0.23

197

Other renal tubulo-interstitial diseases

1.50

0.51

1.5

1.3

5.80

5.89

mmol/l

—

Infections of the skin and subcutaneous tissue

154

1401

1.09

0.51

1.5

1.4

5.75

5.60

mmol/l

0.74

149

1325

Polyarthropathies

193

1185

1.09

0.51

1.3

1.4

5.70

5.67

mmol/l

0.14

176

1126

Coagulation defects, purpura and other haemorrhagic conditions

413

0.82

0.51

1.5

1.4

5.42

5.65

mmol/l

0.89

391

Autoimmune diseases

375

1806

1.06

0.50

1.4

5.73

5.52

mmol/l

1.33

346

1720

Complications of genitourinary prosthetic devices, implants and grafts

1.47

0.50

1.2

1.4

5.46

6.39

mmol/l

—

Acute appendicitis, no complications

171

1569

1.09

0.50

1.5

1.4

5.41

5.61

mmol/l

1.73

160

1488

Unstable angina pectoris

468

1.15

0.50

1.2

6.22

6.18

mmol/l

0.07

443

Excessive attrition of teeth

122

597

1.11

0.49

1.3

1.4

5.73

5.46

mmol/l

2.60

116

569

Transplanted organ and tissue status

144

0.69

0.49

1.2

1.3

6.92

5.98

mmol/l

—

136

Noninfective enteritis and colitis

105

1164

0.90

0.48

1.4

5.50

5.64

mmol/l

0.64

1103

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

249

1909

0.93

0.48

1.3

5.96

5.63

mmol/l

2.23

237

1802

Abnormal findings on examination of blood, without diagnosis

795

1.12

0.48

1.3

6.02

5.91

mmol/l

0.30

750

Abnormal findings on diagnostic imaging of lung

785

0.88

0.48

1.2

1.3

6.06

mmol/l

0.01

738

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

234

0.77

0.48

1.3

5.94

6.08

mmol/l

0.36

222

Appendicitis, broad definition

226

1926

1.07

0.47

1.4

5.48

5.61

mmol/l

1.13

212

1824

Colorectal cancer

344

0.81

0.47

1.1

1.3

6.07

6.15

mmol/l

0.17

322

Other specified disorders of kidney and ureter

1.49

0.47

1.3

1.2

4.96

6.39

mmol/l

—

Deep bite

185

0.76

0.47

1.6

1.4

5.71

5.52

mmol/l

0.28

178

Selective serotonin reuptake inhibitors

335

1662

1.06

0.47

1.4

5.83

5.52

mmol/l

3.47

312

1583

Dizziness and giddiness

199

1498

1.08

0.47

1.3

1.4

5.65

5.73

mmol/l

0.44

182

1418

127

1248

0.91

0.47

1.3

1.4

5.93

5.70

mmol/l

1.22

120

1180

Injuries to the ankle and foot

220

1868

1.07

0.46

1.5

1.4

5.40

5.52

mmol/l

0.77

212

1769

Other disorders of fluid, electrolyte and acid-base balance

441

1.16

0.46

1.2

1.3

6.23

6.03

mmol/l

0.45

419

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

164

0.73

0.45

1.2

1.3

6.47

6.19

mmol/l

0.62

153

Disorders of sclera, cornea, iris and ciliary body

143

1314

1.09

0.45

1.3

1.4

5.70

5.69

mmol/l

0.03

130

1243

Urticaria and erythema

1011

0.90

0.44

1.3

1.4

5.37

5.54

mmol/l

1.03

956

Diseases of appendix

227

1935

1.07

0.44

1.4

5.48

5.62

mmol/l

1.18

213

1831

Viral and other specified intestinal infections

595

0.87

0.44

1.4

1.5

5.34

5.18

mmol/l

0.36

574

Coxarthrosis, primary, with hip surgery

686

1.12

0.43

1.2

6.06

6.14

mmol/l

0.36

642

Other and unspecified dermatitis

119

1302

0.91

0.43

1.4

5.58

5.69

mmol/l

0.52

110

1228

Abdominal aortic aneurysm (AAA)

126

0.71

0.43

1.1

1.2

6.47

6.39

mmol/l

—

119

Glucosamine medication

697

0.89

0.43

1.3

1.2

5.90

6.12

mmol/l

1.62

653

Coronary revascularization (ANGIO or CABG)

504

1.12

0.43

1.2

6.40

6.16

mmol/l

0.88

480

Amputation

129

0.70

0.43

1.1

1.3

7.42

6.27

mmol/l

—

123

Pyogenic granuloma

1.62

0.43

1.2

1.5

5.26

6.25

mmol/l

—

Other arthritis (FG)

706

1.12

0.43

1.2

1.3

5.54

5.76

mmol/l

1.28

670

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

782

1.11

0.43

1.3

1.4

5.80

5.70

mmol/l

0.25

732

Hyperfunction of pituitary gland

113

1.33

0.42

1.5

1.4

5.50

5.55

mmol/l

0.06

113

Other reaction to severe stress, and adjustment disorders

106

1164

0.91

0.42

1.4

5.57

5.35

mmol/l

1.46

100

1108

Nephrotic syndrome

1.56

0.42

1.4

1.3

5.23

6.52

mmol/l

—

Genitourinary diseases

189

881

1.08

0.41

1.4

5.52

5.51

mmol/l

0.02

179

847

Ocular pain

167

1.26

0.41

1.2

1.5

6.41

5.46

mmol/l

0.44

159

1.38

0.41

1.9

1.6

5.16

4.96

mmol/l

—

Other anxiety disorders

162

1332

1.08

0.41

1.5

1.4

5.63

5.30

mmol/l

1.67

157

1264

Carcinoma in situ of rectum

0.00

0.41

0.0

1.2

—

7.56

—

Liposarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.1

—

7.59

—

Atypical virus infections of central nervous system

0.00

0.41

0.0

1.1

—

7.42

—

Oxicams

299

1.14

0.41

1.2

1.3

5.87

5.60

mmol/l

1.17

283

Other autoimmune haemolytic anaemias

0.00

0.41

0.0

1.1

—

7.57

—

Early syphilis

0.00

0.41

0.0

1.3

—

7.46

—

Carcinoma in situ of colon

0.00

0.41

0.0

1.1

—

7.72

—

Xerosis cutis

0.00

0.41

0.0

1.5

—

7.25

—

Respiratory tuberculosis, confirmed

0.00

0.41

0.0

1.2

—

7.72

—

Myotonic disorders

0.00

0.41

0.0

1.1

—

7.17

—

Urticaria due to cold and heat

0.00

0.41

0.0

1.4

—

5.44

—

Acquired stenosis of external ear canal

0.00

0.41

0.0

1.2

—

7.36

—

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.3

—

7.45

—

Other specified and unspecified disorders of conjunctiva

0.00

0.41

0.0

1.2

—

6.06

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

0.00

0.41

0.0

1.2

—

7.43

—

Unspecified human immunodeficiency virus [HIV] disease

0.00

0.41

0.0

1.2

—

7.34

—

Mesial bite

0.00

0.41

0.0

1.5

—

6.42

—

Other papulosquamous disorders

0.00

0.41

0.0

1.1

—

7.24

—

Diseases caused by chlamydiae

0.00

0.41

0.0

1.3

—

5.64

—

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.2

—

7.50

—

Disorders of porphyrin and bilirubin metabolism

0.00

0.41

0.0

1.1

—

7.44

—

Other diseases caused by chlamydiae

0.00

0.41

0.0

1.3

—

5.64

—

Dependence on enabling machines and devices, not elsewhere classified

0.00

0.41

0.0

1.1

—

7.49

—

Benign neoplasm: Bronchus and lung

0.00

0.41

0.0

1.2

—

7.36

—

Benign neoplasm: Bronchus and lung

0.00

0.41

0.0

1.2

—

7.45

—

Other degenerative diseases of the basal ganglia

0.00

0.41

0.0

1.2

—

7.68

—

Type 1 diabetes, wide definition, subgroup 2

0.00

0.41

0.0

1.2

—

5.67

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

0.00

0.41

0.0

1.2

—

7.59

—

Malaise and fatigue

118

900

1.09

0.41

1.2

1.4

5.79

5.72

mmol/l

0.27

109

857

Personal history of allergy to drugs, medicaments and biological substances

0.00

0.40

0.0

1.2

—

6.73

—

Carcinoma in situ of colon

0.00

0.40

0.0

1.2

—

7.48

—

Secondary malignant neoplasm of other and unspecified sites

0.00

0.40

0.0

1.1

—

7.46

—

Infection due to other mycobacteria

0.00

0.40

0.0

1.2

—

7.36

—

Concussion

143

1143

1.08

0.40

1.4

5.62

5.49

mmol/l

0.59

132

1083

Benign neoplasm: Liver

1.47

0.40

1.4

5.06

5.70

mmol/l

—

Hypertensive Renal Disease

1.47

0.40

1.2

1.1

5.90

6.65

mmol/l

—

Other extrapyramidal and movement disorders in other diseases

417

1.15

0.40

1.3

5.65

5.92

mmol/l

1.11

398

Lifestyle-related condition

0.00

0.40

0.0

1.3

—

6.80

—

Viral infections of central nervous system, not elsewhere classified/unspecified

0.00

0.40

0.0

1.1

—

7.20

—

Other and unspecified immunodeficiencies with predominantly antibody defects

0.00

0.40

0.0

1.1

—

7.05

—

Other factor of the environment

0.00

0.40

0.0

1.4

—

6.95

—

Malignant neoplasm of other and unspecified parts of tongue

0.00

0.40

0.0

1.2

—

7.45

—

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

0.00

0.40

0.0

1.2

—

7.27

—

Mumps

1.43

0.39

1.4

1.3

6.32

6.38

mmol/l

—

Carcinoma in situ of breast, other/unspecified

0.00

0.39

0.0

1.1

—

5.72

—

Acute poliomyelitis

0.00

0.39

0.0

1.1

—

7.20

—

Universal erythroderma, KELA reimbursement

0.00

0.39

0.0

1.2

—

7.10

—

Abscess of lung

0.00

0.39

0.0

1.2

—

7.23

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.00

0.39

0.0

1.2

—

7.16

—

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

0.00

0.39

0.0

1.3

—

7.18

—

Motor neuron disease

0.00

0.39

0.0

1.1

—

7.44

—

Myocardial infarction, strict

539

1.11

0.38

1.2

6.00

6.16

mmol/l

0.86

514

Intestinal infectious diseases

280

2064

1.06

0.38

1.3

1.4

5.63

5.56

mmol/l

0.33

256

1960

Lymphoid leukaemia

1.38

0.38

1.3

5.77

6.34

mmol/l

0.63

Inguinal hernia, unilateral

1.39

0.38

1.0

1.3

5.84

6.55

mmol/l

—

Inguinal of femoral hernia, unilateral

1.39

0.38

1.0

1.3

5.84

6.55

mmol/l

—

Femoral hernia, unilateral

1.39

0.38

1.0

1.3

5.84

6.55

mmol/l

—

Benign neoplasm: Tongue

1.39

0.38

1.8

1.1

5.92

6.54

mmol/l

—

Major coronary heart disease event

136

838

1.08

0.38

1.3

1.2

6.14

6.11

mmol/l

0.09

119

794

Benign neoplasm: Skin of other and unspecified parts of face

192

0.78

0.38

1.2

1.3

5.81

5.93

mmol/l

0.15

184

Neoplasms

290

1473

1.06

0.37

1.4

5.38

5.42

mmol/l

0.26

272

1397

Benign neoplasms

333

1769

1.05

0.37

1.4

5.62

5.51

mmol/l

1.02

315

1674

ILD, hospital admission 2, with pulmonary infections

136

0.73

0.37

1.4

1.3

6.29

6.12

mmol/l

—

128

122

1117

1.08

0.37

1.4

5.47

5.55

mmol/l

0.50

117

1057

Benign neoplasm: Caecum

158

0.76

0.37

1.1

1.3

5.86

6.24

mmol/l

0.96

147

Substance abuse

145

1288

1.08

0.37

1.3

1.4

5.87

5.68

mmol/l

1.12

137

1220

Superficial injury of lower leg

572

1.12

0.36

1.4

5.64

5.57

mmol/l

0.15

542

Heart failure, not strict

163

1048

1.07

0.36

1.2

1.3

6.33

5.95

mmol/l

2.08

147

988

Other diseases of pleura

633

0.90

0.36

1.3

1.2

6.18

6.08

mmol/l

0.26

595

Coxarthrosis [arthrosis of hip](FG)

108

717

1.09

0.36

1.2

6.00

6.10

mmol/l

0.52

100

678

Allergic asthma (mode), excluding more controls

693

1.11

0.36

1.5

1.4

5.38

5.36

mmol/l

0.04

668

Other complications of surgical and medical care, not elsewhere classified

189

1.22

0.36

1.3

1.4

5.49

5.76

mmol/l

0.59

180

Malignant neoplasm of ovary

0.65

0.35

1.0

1.4

5.74

5.64

mmol/l

—

Benign neoplasm: Caecum

157

0.76

0.35

1.1

1.3

5.86

6.14

mmol/l

0.65

149

Emergency coronary revascularization (for ACS)

589

1.10

0.35

1.2

6.35

6.16

mmol/l

0.70

557

Cystic kidney disease

1.43

0.35

1.7

1.4

5.52

6.22

mmol/l

—

Postprocedural disorders of digestive system, not elsewhere classified

1.43

0.35

1.2

1.3

5.58

6.46

mmol/l

—

Benign neoplasm: Skin of other and unspecified parts of face

190

0.79

0.35

1.2

1.3

5.81

5.90

mmol/l

0.10

179

Female infertility, tubal origin

145

0.76

0.34

1.2

1.5

6.39

5.29

mmol/l

0.82

140

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

405

0.86

0.34

1.3

1.4

5.30

5.62

mmol/l

1.36

383

1.37

0.34

1.5

5.19

6.18

mmol/l

—

Dermatitis and eczema

334

2093

1.05

0.33

1.4

5.45

5.61

mmol/l

1.83

314

1980

Infections with a predominantly sexual mode of transmission

1042

0.92

0.33

1.3

1.5

5.35

5.30

mmol/l

0.24

994

Melanocytic naevi

793

0.91

0.33

1.4

5.47

5.60

mmol/l

0.37

748

Congenital deformities of feet

1.31

0.33

1.5

5.20

5.87

mmol/l

—

Benign neoplasm: Other and unspecified parts of mouth

1.31

0.33

1.7

1.3

5.55

6.35

mmol/l

—

Open wound of hip and thigh

1.31

0.33

1.5

4.92

6.14

mmol/l

—

Other maltreatment syndromes

1.31

0.33

1.2

1.4

5.85

6.15

mmol/l

—

Paralytic ileus

1.31

0.33

1.2

1.3

6.99

6.46

mmol/l

—

Open wound of head

111

1012

1.08

0.33

1.2

1.3

5.67

5.84

mmol/l

1.21

103

956

122

1204

0.93

0.32

1.3

1.4

5.93

5.72

mmol/l

1.03

115

1140

Allergic asthma (mode)

698

1.10

0.32

1.5

1.4

5.38

mmol/l

0.01

673

Congenital malformations of breast

1.28

0.32

1.7

1.6

5.00

5.14

mmol/l

—

Major anomalies of jaw size

1.28

0.32

1.5

4.82

6.18

mmol/l

—

Organic, including symptomatic, mental disorders

541

1.09

0.31

1.2

6.23

6.11

mmol/l

0.29

505

Suppurative otitis media, unspecified

1.35

0.31

1.6

5.79

5.64

mmol/l

—

Autoimmune diseases related-to ILD

247

2069

1.05

0.31

1.3

1.4

5.54

5.62

mmol/l

0.54

224

1963

Lesion of radial nerve

1.32

0.31

1.3

5.76

6.34

mmol/l

—

Certain infectious and parasitic diseases

350

1681

1.04

0.31

1.3

1.4

5.66

5.54

mmol/l

0.96

330

1590

Spermatocele

0.73

0.30

1.1

1.3

6.03

6.51

mmol/l

—

Other bacterial diseases

243

1599

1.05

0.30

1.2

1.3

6.08

5.73

mmol/l

3.63

229

1506

Other coagulation defects

153

0.78

0.30

1.4

5.43

5.70

mmol/l

0.40

148

Syncope and collapse

102

837

1.08

0.30

1.3

5.71

5.77

mmol/l

0.24

795

Arthropathies in other diseases classified elsewhere

1.30

0.30

1.0

1.3

6.01

5.89

mmol/l

—

Other disorders of ear

240

1522

1.05

0.30

1.2

1.3

5.87

5.79

mmol/l

0.59

223

1437

Contact with other hot fluids

1.25

0.29

1.4

1.5

4.92

5.95

mmol/l

—

Stroke, including SAH

115

793

1.07

0.29

1.2

1.3

6.05

6.07

mmol/l

0.09

107

747

Temporomandibular joint disorders, including avohilmo

148

1392

1.06

0.29

1.5

1.4

5.25

5.38

mmol/l

1.15

140

1325

Postprocedural musculoskeletal disorders, not elsewhere classified

107

0.75

0.29

1.6

1.3

5.78

6.19

mmol/l

—

100

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

107

0.75

0.29

1.5

1.3

5.96

6.10

mmol/l

—

102

Bronchiectasis

106

0.75

0.29

1.5

1.3

6.00

6.21

mmol/l

—

100

Injury of unspecified body region

130

1.23

0.28

1.1

1.4

5.65

5.79

mmol/l

0.20

125

Benign neoplasm of ovary

376

0.88

0.28

1.4

1.3

5.41

5.76

mmol/l

1.78

350

Other disorders of penis

112

1.25

0.28

1.3

6.04

6.47

mmol/l

0.72

105

Complications of surgical and medical care, not elsewhere classified

280

1924

1.04

0.28

1.3

1.4

5.71

5.64

mmol/l

0.37

267

1814

Other diseases of blood and blood-forming organs

103

1.26

0.28

1.2

1.3

6.02

6.09

mmol/l

0.09

Venous thromboembolism

1012

0.93

0.28

1.3

5.73

5.92

mmol/l

1.15

953

Bleeding

169

1298

0.95

0.28

1.2

1.3

6.10

5.85

mmol/l

1.61

159

1218

Fibrosis and cirrhosis of liver

116

0.78

0.27

1.0

1.3

6.26

6.17

mmol/l

—

110

Other disorders starting during childhood or adolescence

118

0.76

0.27

1.8

1.6

4.77

4.95

mmol/l

—

113

ILD, hospital admissions 3, with pneumonia sepsis

119

0.76

0.27

1.4

1.3

6.34

6.22

mmol/l

—

112

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

584

0.92

0.26

1.2

1.3

5.94

5.85

mmol/l

0.27

548

Benign neoplasm of ovary

374

0.88

0.26

1.4

1.3

5.41

5.81

mmol/l

2.17

354

Adjustment and management of implanted device

236

0.85

0.26

1.1

1.3

6.03

6.18

mmol/l

0.27

225

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

129

1189

1.06

0.26

1.3

1.4

5.66

5.75

mmol/l

0.45

123

1127

5-aminosalicylic acid

510

0.90

0.26

1.4

5.41

5.57

mmol/l

0.47

486

Other disorders of skin and subcutaneous tissue

147

1423

0.95

0.26

1.2

1.4

5.84

5.78

mmol/l

0.22

140

1336

Complications associated with artificial fertilization

0.70

0.26

1.0

1.5

5.02

5.11

mmol/l

—

Parodontitis or/and operation codes

197

1115

1.05

0.26

1.3

1.4

5.90

5.60

mmol/l

2.19

182

1041

IBD patients in KELA-register

562

0.91

0.26

1.4

5.32

5.55

mmol/l

0.85

533

Social phobias

246

0.85

0.26

1.4

1.5

5.60

5.17

mmol/l

1.53

237

Pneumonias (Asthma/COPD co-morbidities)

274

1975

0.96

0.26

1.3

1.4

5.80

5.59

mmol/l

2.21

252

1872

Cervicocranial syndrome

197

1.17

0.25

1.4

5.79

5.73

mmol/l

0.08

192

Nontoxic single thyroid nodule

132

1.21

0.25

1.4

5.73

5.83

mmol/l

0.15

127

Acute appendicitis

208

1875

1.05

0.25

1.4

5.47

5.61

mmol/l

1.27

196

1780

ILD medications: immunosuppressive drugs

157

1586

0.95

0.25

1.4

5.55

5.66

mmol/l

0.44

146

1499

Drug-induced neutropenia

114

1.23

0.25

1.5

1.3

7.00

6.01

mmol/l

0.64

107

Complications of medical and surgical care

173

1723

0.95

0.24

1.3

5.88

5.70

mmol/l

0.92

162

1624

Appendectomy

199

1832

1.05

0.24

1.4

5.40

5.56

mmol/l

1.34

182

1743

Injuries to unspecified part of trunk, limb or body region

170

1.18

0.24

1.1

1.4

5.60

5.77

mmol/l

0.32

163

LSIL lesion of the cervix uteri, vagina or vulva

436

1.10

0.24

1.3

1.5

5.31

5.25

mmol/l

0.15

415

Other diseases of liver

331

1.12

0.24

1.3

5.74

5.86

mmol/l

0.33

314

Traumatic subdural haemorrhage

145

0.81

0.24

1.3

1.2

5.82

6.37

mmol/l

1.30

138

Dermatitis

145

1526

0.95

0.23

1.4

5.58

5.69

mmol/l

0.69

134

1440

Inflammatory bowel disease, strict (require KELA)

558

0.91

0.23

1.4

5.32

5.54

mmol/l

0.83

529

Asthma and allergy

384

1.11

0.23

1.6

1.5

5.20

5.26

mmol/l

0.19

373

Other chronic obstructive pulmonary disease

563

1.08

0.23

1.4

1.2

5.98

6.17

mmol/l

1.26

527

Disorders of skin appendages

127

1339

0.95

0.23

1.3

1.4

5.67

5.51

mmol/l

0.73

120

1267

Asthma and allergy, excluding more controls

385

1.10

0.22

1.6

1.5

5.20

5.24

mmol/l

0.11

374

Coeliac disease

266

1.13

0.22

1.3

1.4

5.72

5.63

mmol/l

0.24

254

Benign neoplasm: Liver/bile ducts

1.25

0.22

1.4

5.06

6.21

mmol/l

—

Post-traumatic wound infection, not elsewhere classified

1.25

0.22

1.0

1.4

6.00

6.33

mmol/l

—

Carcinoma in situ of skin of other and unspecified parts of face

0.75

0.22

1.0

1.2

6.27

6.25

mmol/l

—

Nail disorders

146

0.82

0.22

1.6

1.4

5.05

5.77

mmol/l

1.44

138

243

1.13

0.22

1.3

1.2

6.09

6.27

mmol/l

0.26

225

Other and unspecified injuries of shoulder and upper arm

1.22

0.22

1.4

5.10

6.26

mmol/l

—

Other benign neoplasms of connective and other soft tissue

172

1.16

0.22

1.3

5.65

5.82

mmol/l

0.33

163

Malignant melanoma, excluding all cancers (controls excluding all cancers)

284

0.88

0.22

1.4

1.3

5.97

6.07

mmol/l

0.24

268

Mental and behavioural disorders due to psychoactive substance use

147

1322

1.05

0.21

1.3

1.4

5.86

5.67

mmol/l

1.11

138

1251

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

8.02

—

Surgical ablation of atrial fibrillation

0.00

0.21

0.0

1.2

—

7.92

—

Mastocytosis

0.00

0.21

0.0

1.1

—

8.12

—

Mandibular prognathia AND surgery (LeFortI or BSSRO)

0.00

0.21

0.0

1.2

—

7.74

—

ILD medications: nintedanib

0.00

0.21

0.0

1.2

—

8.13

—

Melanoma in situ of lower limb, including hip

0.00

0.21

0.0

1.1

—

5.88

—

Melanoma in situ of lower limb, including hip

0.00

0.21

0.0

1.1

—

5.93

—

Other and unspecified disorders of binocular movement

0.00

0.21

0.0

1.1

—

7.71

—

Other/unspecified crystal arthropathies

0.00

0.21

0.0

1.1

—

8.49

—

Muscle wasting and atrophy, not elsewhere classified

0.00

0.21

0.0

1.3

—

7.94

—

Malignant neoplasm of palate, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

8.28

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.21

0.0

1.2

—

8.22

—

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

0.00

0.21

0.0

1.2

—

7.95

—

Other adrenocortical overactivity

0.00

0.21

0.0

1.4

—

5.76

—

Nail dystrophy

0.00

0.21

0.0

1.4

—

5.92

—

Disorders of male genital organs in diseases classified elsewhere

0.00

0.21

0.0

1.3

—

8.14

—

Injury of cranial nerves

0.00

0.21

0.0

1.2

—

5.91

—

Glaucoma secondary to eye trauma

0.00

0.21

0.0

1.1

—

8.50

—

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

8.21

—

Contact with other specified venomous animals

0.00

0.21

0.0

1.2

—

5.76

—

Disorders of plasma-protein metabolism, not elsewhere classified

0.00

0.21

0.0

1.3

—

8.03

—

Pyoderma gangrenosum

0.00

0.21

0.0

1.2

—

8.00

—

Other and unspecified disorders of pigmentation

0.00

0.21

0.0

1.1

—

7.70

—

Narcolepsy and cataplexy

0.00

0.21

0.0

1.5

—

7.56

—

Malignant neoplasm of parotid gland

0.00

0.21

0.0

1.0

—

8.47

—

Sequelae of poliomyelitis

0.00

0.21

0.0

1.1

—

8.40

—

Other bursitis of elbow

0.00

0.21

0.0

1.3

—

8.11

—

Bullous keratopathy

0.00

0.21

0.0

1.2

—

8.37

—

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

8.08

—

0.00

0.21

0.0

1.2

—

5.77

—

Meningococcal infection

0.00

0.21

0.0

1.1

—

7.69

—

Unspecified parasitic disease

0.00

0.21

0.0

1.1

—

6.18

—

Use of entacapone

0.00

0.21

0.0

1.2

—

8.50

—

Benign neoplasm: Nasopharynx

0.00

0.21

0.0

1.1

—

6.36

—

Benign neoplasm: Nasopharynx

0.00

0.21

0.0

1.1

—

6.36

—

Other congenital malformations of intestine

0.00

0.21

0.0

1.3

—

8.19

—

Other and unspecified acquired haemolytic anaemias

0.00

0.21

0.0

1.1

—

8.32

—

Benign neoplasm: Rectum/anal canal icd-9

0.00

0.21

0.0

1.2

—

8.01

—

Gastrointestinal stromal tumor and sarcoma

0.00

0.21

0.0

1.0

—

8.51

—

ILD medications: acetylcysteine

0.00

0.21

0.0

1.2

—

8.29

—

Lung transplant status

0.00

0.21

0.0

1.1

—

7.79

—

Lung transplantation

0.00

0.21

0.0

1.1

—

7.79

—

Gilbert syndrome

0.00

0.21

0.0

1.0

—

7.90

—

Dacryoadenitis

0.00

0.21

0.0

1.2

—

6.27

—

Malignant neoplasm of bone and articular cartilage

0.00

0.21

0.0

1.2

—

7.78

—

Hypertension, Pulmonary Arterial

0.00

0.21

0.0

1.2

—

7.54

—

Carcinoid syndrome

0.00

0.21

0.0

1.2

—

8.12

—

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

8.12

—

Hyperosmolality and hypernatraemia

0.00

0.21

0.0

1.2

—

8.21

—

Torsion of testis

0.00

0.21

0.0

1.3

—

8.02

—

Malignant melanoma

241

0.87

0.21

1.4

1.3

5.94

6.06

mmol/l

0.25

228

Acute sinusitis

160

1426

1.05

0.21

1.4

5.56

5.52

mmol/l

0.17

153

1357

Benign neoplasm: Descending colon

104

0.77

0.21

1.1

1.3

5.89

6.32

mmol/l

—

Benign neoplasm: Liver

1.16

0.21

1.4

5.06

5.73

mmol/l

—

Lupus erythematosus

1.16

0.21

1.2

1.4

5.46

6.32

mmol/l

—

Myocardial infarction

579

1.07

0.21

1.2

6.06

6.17

mmol/l

0.50

551

Stroke, excluding SAH

106

744

1.06

0.21

1.2

1.3

6.08

mmol/l

0.01

700

Personal history of allergy to analgesic agent

0.00

0.21

0.0

1.2

—

7.18

—

Other and unspecified disorders of adult personality and behaviour

0.00

0.21

0.0

1.5

—

5.50

—

Intracranial injury

132

1339

0.95

0.21

1.4

5.65

5.61

mmol/l

0.12

123

1271

Pedal cyclist injured in collision with pedestrian or animal

0.00

0.21

0.0

1.4

—

7.66

—

Carcinoma in situ of rectum

0.00

0.21

0.0

1.1

—

7.90

—

Folate deficiency anaemia

0.00

0.21

0.0

1.2

—

7.91

—

Haemorrhagic disorder due to circulating anticoagulants

0.00

0.21

0.0

1.1

—

8.12

—

Spondylopathies in diseases classified elsewhere

0.00

0.21

0.0

1.2

—

7.81

—

Measles

0.00

0.21

0.0

1.3

—

5.87

—

Whooping cough

0.00

0.20

0.0

1.6

—

7.00

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.20

0.0

1.2

—

7.23

—

Benign neoplasm: Bone and articular cartilage, unspecified

0.00

0.20

0.0

1.2

—

7.24

—

Kela reimbursement Agammaglobulinemia (D80-84)

0.00

0.20

0.0

1.1

—

5.81

—

Other nonthrombocytopenic purpura

0.00

0.20

0.0

1.4

—

7.50

—

Open wound of neck

0.00

0.20

0.0

1.3

—

7.67

—

Severe visual impairment, monocular

0.00

0.20

0.0

1.1

—

7.76

—

Other and unspecified injuries of neck

0.00

0.20

0.0

1.3

—

5.92

—

Exposure to unspecified smoke, fire and flames

0.00

0.20

0.0

1.2

—

7.56

—

Exposure to excessive natural cold

0.00

0.20

0.0

1.3

—

7.50

—

Exfoliative dermatitis

0.00

0.20

0.0

1.2

—

7.60

—

Atypical mycobacterium lung infection

0.00

0.20

0.0

1.2

—

7.80

—

Gonarthrosis, primary, with knee surgery

100

772

1.06

0.20

1.3

1.2

6.01

6.12

mmol/l

0.60

727

Other and unspecified disorders of skin and subcutaneous tissue

111

0.81

0.20

1.0

1.4

5.22

5.91

mmol/l

—

104

Other specified/unspecified systemic involvement of connective tissue

112

0.80

0.20

1.2

1.4

5.46

5.86

mmol/l

—

107

All pneumoniae

279

1988

0.97

0.20

1.3

1.4

5.78

5.59

mmol/l

1.88

257

1884

L02BB Anti-androgens

112

0.80

0.20

1.0

1.2

6.61

6.43

mmol/l

—

105

Congenital malformations, deformations and chromosomal abnormalities

172

1716

0.96

0.20

1.5

1.4

5.41

5.46

mmol/l

0.29

166

1629

Nonsuppurative otitis media

666

1.06

0.20

1.5

5.04

5.17

mmol/l

0.68

636

Pneumococcal septicemia

1.20

0.19

1.7

1.4

5.83

6.24

mmol/l

—

Major coronary heart disease event excluding revascularizations

117

767

1.05

0.19

1.2

6.10

6.13

mmol/l

0.09

101

728

Dyspnoea

239

1768

1.04

0.19

1.3

1.4

5.83

5.68

mmol/l

1.39

221

1672

COPD (mode)

404

1.08

0.19

1.4

1.2

5.91

6.14

mmol/l

1.27

381

Artificial joint operation, meniscal resection

209

1340

1.04

0.19

1.3

6.03

5.92

mmol/l

0.47

194

1264

Seborrhoeic keratosis

385

0.91

0.19

1.1

1.3

5.93

6.06

mmol/l

0.39

358

Intracerebral haemorrhage

154

0.84

0.19

1.0

1.3

6.29

6.21

mmol/l

0.12

147

Irregular menses

185

1444

1.04

0.19

1.5

1.4

5.56

5.28

mmol/l

2.86

169

1377

L02BG Aromatase inhibitors

569

1.07

0.18

1.1

1.3

5.85

5.88

mmol/l

0.08

530

Anisometropia and aniseikonia

1.13

0.18

1.2

1.4

6.35

6.07

mmol/l

—

Pneumonia derived septicemia

1.13

0.18

1.7

1.4

5.83

6.18

mmol/l

—

Cerebrovascular diseases

137

1026

0.96

0.18

1.3

5.98

6.00

mmol/l

0.05

129

963

Melanocytic naevi of trunk

280

0.89

0.18

1.4

5.28

5.63

mmol/l

0.92

269

Coronary artery bypass grafting

271

1.10

0.18

1.2

6.46

6.29

mmol/l

0.28

259

Disorders of parathyroid gland

338

0.91

0.18

1.1

1.3

6.13

6.03

mmol/l

0.11

318

Visual field defects

132

0.83

0.18

1.1

1.3

5.70

5.99

mmol/l

0.47

127

Systemic lupus erythematosus, unspecified

1.21

0.18

1.3

1.4

5.39

6.01

mmol/l

—

Aplastic and other anaemias

745

0.94

0.18

1.1

1.3

6.00

5.94

mmol/l

0.11

700

Renal failure

605

0.94

0.17

1.1

1.2

6.51

6.05

mmol/l

0.89

567

Complications following abortion and ectopic and molar pregnancy

1.15

0.17

1.6

1.3

5.61

5.58

mmol/l

—

Diplopia

233

1.12

0.17

1.5

1.3

5.59

5.85

mmol/l

0.66

222

Senile cataract

131

777

1.05

0.17

1.2

1.3

6.19

6.08

mmol/l

0.46

118

730

Ischaemic Stroke, excluding all haemorrhages

689

1.05

0.17

1.3

6.03

6.11

mmol/l

0.25

651

Agranulocytosis

195

1.13

0.17

1.4

1.3

7.20

5.88

mmol/l

0.81

185

Disorders of other endocrine glands

117

1100

1.05

0.17

1.4

5.91

5.53

mmol/l

1.05

109

1040

Ulcerative colitis (strict definition, require KELA)

382

0.92

0.17

1.3

1.4

5.30

5.60

mmol/l

1.22

362

Other diseases of intestine

186

1.13

0.16

1.2

1.3

5.89

6.03

mmol/l

0.23

177

Alzheimer’s disease (Atypical or mixed), excluding more controls

1.17

0.16

1.6

1.1

5.96

6.79

mmol/l

—

Injuries to the wrist and hand

299

2109

1.03

0.16

1.3

1.4

5.64

5.56

mmol/l

0.57

286

1989

Atopic dermatitis

179

1580

0.97

0.16

1.5

1.4

5.16

5.42

mmol/l

3.51

170

1499

Neuromuscular dysfunction of bladder

158

1.14

0.16

1.4

5.90

5.98

mmol/l

0.14

149

Benign neoplasms

278

1530

1.03

0.16

1.4

5.49

5.42

mmol/l

0.44

261

1450

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

370

0.92

0.16

1.3

1.4

5.33

5.59

mmol/l

0.96

351

Basal cell carcinoma, including avohilmo

728

0.95

0.15

1.2

1.3

6.07

6.13

mmol/l

0.20

681

Codeine

322

1726

1.03

0.15

1.4

5.74

5.50

mmol/l

3.30

304

1635

Influenza and pneumonia

306

2062

0.98

0.15

1.3

1.4

5.77

5.56

mmol/l

2.33

284

1954

Retinal vascular occlusion

178

1.12

0.15

1.3

6.52

6.14

mmol/l

0.30

167

Lichen simplex chronicus and prurigo

102

1.18

0.15

1.2

1.4

6.11

6.02

mmol/l

0.07

Melanocytic naevi

759

0.95

0.15

1.4

5.47

5.54

mmol/l

0.16

720

Injuries to the elbow and forearm

181

1688

0.97

0.15

1.3

1.4

5.60

5.61

mmol/l

0.05

171

1592

Other diseases of arteries and capillaries

150

0.87

0.14

1.2

1.3

6.76

5.99

mmol/l

0.32

144

Other and unspecified glaucoma

0.80

0.14

1.1

1.2

7.44

6.26

mmol/l

—

Myocardial infarction, without ST-elevation

510

0.94

0.14

1.2

6.12

6.21

mmol/l

0.28

475

Malignant neoplasm of rectum

139

0.86

0.14

1.1

1.2

5.93

6.17

mmol/l

0.31

133

Injury of muscle and tendon at wrist and hand level

233

0.90

0.14

1.2

1.3

5.93

5.88

mmol/l

0.09

221

Sulfasalazine

706

0.95

0.14

1.4

5.43

5.71

mmol/l

1.75

664

Retinal vascular disorders

179

1.12

0.14

1.3

6.52

6.13

mmol/l

0.30

168

ILD medications: prednisolone, methylprednisolone, prednisone

335

1935

0.98

0.14

1.3

1.4

5.74

5.56

mmol/l

1.60

311

1833

Dystonia

0.82

0.13

1.1

1.4

5.73

5.92

mmol/l

—

Acute laryngitis and tracheitis

300

0.92

0.13

1.4

1.5

4.88

5.26

mmol/l

1.69

289

Colorectal adenocarcinoma

284

0.92

0.13

1.1

1.3

6.18

6.15

mmol/l

0.06

265

Alcohol use disorder, Swedish definition

116

1117

0.96

0.13

1.3

6.02

5.76

mmol/l

1.43

109

1059

Coxarthrosis, primary

105

876

1.04

0.13

1.2

6.08

6.12

mmol/l

0.18

819

Unspecified/other endometriosis

354

1.07

0.13

1.3

1.6

5.06

5.11

mmol/l

0.15

343

Purpura and other haemorrhagic conditions

242

0.91

0.13

1.5

1.4

5.42

5.77

mmol/l

1.31

231

Osteopathies and chondropathies

116

1140

0.96

0.13

1.3

5.75

5.76

mmol/l

0.04

109

1075

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

283

0.92

0.12

1.1

1.2

6.18

6.21

mmol/l

0.06

265

Endometriosis ASRM stages 1,2

550

0.95

0.12

1.4

1.5

5.33

5.35

mmol/l

0.09

523

Correction of physiology of bite - demanding therapy visit

169

0.89

0.12

1.4

1.5

5.06

5.56

mmol/l

1.37

164

Other respiratory diseases principally affecting the interstitium

252

0.91

0.12

1.4

1.3

5.96

6.13

mmol/l

0.28

237

Substance abuse, excluding more controls

145

1230

1.03

0.12

1.3

1.4

5.87

5.58

mmol/l

2.09

137

1167

Codeine or tramadol medication

361

1961

1.02

0.12

1.4

5.75

5.55

mmol/l

2.97

340

1858

Valvular heart disease excluding rheumatic fever

625

0.96

0.12

1.1

1.3

6.02

6.05

mmol/l

0.07

596

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

976

0.96

0.12

1.4

1.5

5.47

5.23

mmol/l

1.08

931

Carbimazole or st.post thyroidectomy, condition for graves disease

502

1.06

0.12

1.5

1.4

5.84

5.66

mmol/l

0.31

475

Medicines for HER+ breast cancer

743

0.96

0.12

1.2

1.3

5.84

5.83

mmol/l

0.02

696

Ulcerative colitis

569

0.95

0.12

1.3

1.4

5.51

5.61

mmol/l

0.30

541

Other interstitial pulmonary diseases

220

0.91

0.12

1.4

1.3

6.08

6.14

mmol/l

0.07

205

Non-rheumatic valve diseases

616

0.96

0.11

1.1

1.3

6.04

6.06

mmol/l

0.04

587

Fracture of forearm

131

1265

0.97

0.11

1.3

1.4

5.56

5.68

mmol/l

0.75

124

1189

Other cataract

590

0.96

0.11

1.2

1.3

6.09

6.06

mmol/l

0.06

558

Other specified/unspecified arthritis

592

1.05

0.11

1.2

1.3

5.53

5.77

mmol/l

1.23

566

Heart failure,strict

611

1.04

0.11

1.2

1.3

6.23

6.12

mmol/l

0.43

574

Interstitial lung disease

219

0.91

0.11

1.4

1.3

6.08

6.14

mmol/l

0.07

205

Interstitial lung disease endpoints

219

0.91

0.11

1.4

1.3

6.08

6.14

mmol/l

0.07

205

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

123

1174

0.97

0.10

1.2

1.3

5.99

5.90

mmol/l

0.32

112

1101

Fever of other and unknown origin

127

1212

0.97

0.10

1.3

1.4

5.63

5.62

mmol/l

0.05

120

1153

Psoriasis

603

1.04

0.10

1.4

1.3

5.76

5.84

mmol/l

0.28

574

ILD medications

353

1970

0.98

0.10

1.3

1.4

5.69

5.55

mmol/l

1.25

332

1866

Acne vulgaris

249

0.92

0.10

1.3

1.6

5.20

5.09

mmol/l

0.18

237

Other disorders of the genitourinary system

212

1.09

0.10

1.3

5.37

6.03

mmol/l

2.50

200

Benign neoplasm: Liver/bile ducts

1.14

0.10

1.4

5.06

6.21

mmol/l

—

Follow-up examination after treatment for malignant neoplasms

135

1.11

0.09

1.2

1.3

6.26

6.30

mmol/l

0.05

126

Endometriosis of pelvic peritoneum

527

0.95

0.09

1.4

1.5

5.33

5.31

mmol/l

0.08

508

Disorders of ocular muscles, binocular movement, accommodation and refraction

136

1314

1.03

0.09

1.4

5.48

5.49

mmol/l

0.03

129

1244

Inflammatory bowel disease treatment related agents

358

2002

1.02

0.09

1.3

1.4

5.66

5.57

mmol/l

0.75

332

1900

Inflammatory bowel disease

767

0.96

0.09

1.4

5.49

5.61

mmol/l

0.46

724

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

203

1623

1.02

0.09

1.4

5.44

5.47

mmol/l

0.15

194

1535

Unspecified dementia

1.13

0.09

1.2

1.1

6.17

6.40

mmol/l

0.28

Abnormal findings in secretions and smears from cervix uteri vagina vulva

186

1431

1.02

0.09

1.4

5.41

5.35

mmol/l

0.38

178

1355

Undefined dementia

1.13

0.09

1.3

1.1

6.17

6.48

mmol/l

0.41

COPD

589

1.04

0.08

1.4

1.3

5.98

6.15

mmol/l

1.10

552

Cysts of oral region, not elsewhere classified

1.07

0.08

1.7

1.3

5.03

5.87

mmol/l

—

Adrenocortical insufficiency

1.05

0.08

1.2

1.5

8.50

6.11

mmol/l

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

154

0.91

0.08

1.1

1.2

5.80

6.38

mmol/l

1.52

144

ILD, hospital admissions

216

0.93

0.08

1.4

1.3

6.08

6.14

mmol/l

0.07

202

Injuries to the abdomen, lower back, lumbar spine and pelvis

840

0.97

0.08

1.3

1.4

5.53

5.67

mmol/l

0.75

796

Pain associated with micturition

224

1.07

0.08

1.3

1.4

5.80

5.77

mmol/l

0.05

214

Heart failure, strict

650

1.03

0.08

1.2

1.3

6.24

6.15

mmol/l

0.36

609

SLE, strict definition

1.06

0.08

1.3

1.5

5.39

5.94

mmol/l

—

SLE, ICD10

1.06

0.08

1.3

1.5

5.39

5.94

mmol/l

—

Disorders of lens

146

901

1.02

0.07

1.2

1.3

6.16

6.03

mmol/l

0.61

132

846

Ulcerative colitis (strict definition, all Crohn cases excluded)

327

0.95

0.07

1.2

1.4

5.28

5.60

mmol/l

1.10

311

Polyp of the female genital tract

521

0.97

0.07

1.3

1.4

5.79

5.50

mmol/l

2.46

499

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

626

1.03

0.07

1.5

1.6

5.16

5.05

mmol/l

0.48

598

Falls/tendency to fall

374

1850

1.01

0.07

1.4

5.60

5.54

mmol/l

0.32

354

1749

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

147

1.09

0.07

1.1

1.3

5.96

6.22

mmol/l

0.45

137

Foreign body in respiratory tract

1.06

0.07

1.3

1.4

5.02

5.99

mmol/l

—

COPD related to multimorbidity

488

0.97

0.07

1.4

1.2

6.05

6.21

mmol/l

0.83

460

Female infertility, cervigal, vaginal, other or unspecified origin

122

799

1.02

0.07

1.6

1.5

5.24

5.18

mmol/l

0.15

116

770

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

269

1915

0.99

0.06

1.3

1.4

5.81

5.62

mmol/l

1.77

247

1814

Benzodiazepine use

292

2051

1.01

0.06

1.3

1.4

5.84

5.57

mmol/l

3.68

273

1940

Ptosis of eyelid

173

0.92

0.06

1.5

1.3

5.52

5.97

mmol/l

2.16

164

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

187

1.07

0.06

1.2

1.3

6.13

6.20

mmol/l

0.11

175

Melanocytic naevi of trunk

264

0.95

0.06

1.4

5.28

5.63

mmol/l

0.90

255

Depression medications

126

622

1.02

0.05

1.4

1.5

5.60

5.00

mmol/l

7.13

116

599

Other benign neoplasms of connective and other soft tissue

188

1.06

0.05

1.3

5.65

5.84

mmol/l

0.42

182

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

576

0.97

0.05

1.2

1.3

5.88

5.76

mmol/l

0.40

549

Non-ischemic cardiomyopathy

333

1.04

0.05

1.0

1.2

6.40

6.13

mmol/l

0.59

317

Injuries to the shoulder and upper arm

199

1649

1.01

0.04

1.2

1.4

5.83

5.74

mmol/l

0.71

186

1551

COPD, hospital admissions

613

1.02

0.04

1.4

1.2

5.97

6.13

mmol/l

1.05

573

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

150

1.07

0.04

1.1

1.3

5.96

6.22

mmol/l

0.47

139

Pneumonia, organism unspecified

238

1738

0.99

0.04

1.3

1.4

5.81

5.66

mmol/l

1.13

217

1645

Vasomotor and allergic rhinitis

114

1106

1.02

0.04

1.4

5.36

5.45

mmol/l

0.45

109

1051

Sensorineural hearing loss

158

1092

1.01

0.04

1.2

1.3

5.93

5.94

mmol/l

0.06

148

1024

Benign mammary dysplasia

281

0.96

0.04

1.3

5.39

5.74

mmol/l

1.61

264

Other noninflammatory disorders of vagina

190

1.05

0.04

1.4

1.5

5.35

5.43

mmol/l

0.15

183

Use of hypnotics and sedatives

302

1760

0.99

0.04

1.3

1.4

5.93

5.65

mmol/l

3.40

284

1662

Fracture of lower leg, including ankle

127

1248

1.01

0.03

1.4

1.3

5.86

5.75

mmol/l

0.50

117

1178

Malignant neoplasm of breast, HER-positive

664

0.98

0.03

1.2

1.3

5.94

5.87

mmol/l

0.18

618

Benign neoplasm: Skin of eyelid, including canthus

270

1.04

0.03

1.4

1.3

5.40

5.97

mmol/l

2.41

255

Injuries to the thorax

873

0.98

0.03

1.3

6.23

5.81

mmol/l

0.74

819

All dysplastic lesions of the cervix uteri

971

0.99

0.03

1.4

1.5

5.42

5.23

mmol/l

1.21

926

Spontaneous rupture of synovium and tendon

112

1.07

0.03

1.3

5.74

6.15

mmol/l

0.68

106

Erosion of teeth, including avohilmo

511

1.02

0.03

1.4

5.94

5.39

mmol/l

0.54

488

Dysplasia of cervi uteri

768

0.99

0.02

1.5

5.42

5.19

mmol/l

1.69

742

Myocardial infarction, with ST-elevation

239

0.96

0.02

1.2

5.73

6.22

mmol/l

1.42

225

Behavioural syndromes associated with physiological disturbances and physical factors

101

1022

0.99

0.02

1.3

1.5

5.57

5.30

mmol/l

1.04

975

Dislocation, sprain and strain of joints and ligaments of knee

177

1630

1.01

0.02

1.4

5.61

5.57

mmol/l

0.25

172

1542

Female infertility

134

819

1.01

0.02

1.6

1.5

5.31

5.18

mmol/l

0.35

126

790

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

266

1656

1.01

0.02

1.3

1.4

5.79

5.57

mmol/l

2.15

245

1570

266

1656

1.01

0.02

1.3

1.4

5.79

5.57

mmol/l

2.15

245

1570

Stenosis and insufficiency of lacrimal passages

162

1.05

0.02

1.2

1.3

5.32

5.76

mmol/l

1.75

154

Hydronephrosis

212

1.04

0.02

1.7

1.4

5.34

5.89

mmol/l

1.77

199

Bacterial Sepsis

685

1.01

0.02

1.2

1.3

6.06

5.93

mmol/l

0.42

647

Transport accidents

142

1249

1.01

0.02

1.4

5.81

5.49

mmol/l

1.00

133

1181

Mental and behavioural disorders due to alcohol

113

1090

1.01

0.01

1.3

1.4

5.95

5.75

mmol/l

0.87

107

1035

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

147

0.95

0.01

1.1

1.2

5.94

6.17

mmol/l

0.35

140

COPD, early/later onset

617

1.01

0.01

1.4

1.2

5.97

6.13

mmol/l

1.06

577

Sarcoidosis

227

0.97

0.01

1.3

6.05

5.96

mmol/l

0.10

216

Intracranial trauma

160

1188

1.01

0.01

1.4

5.63

5.49

mmol/l

0.82

148

1125

Fracture at wrist and hand level

742

1.01

0.01

1.3

1.4

5.66

5.65

mmol/l

0.04

701

Disorders of refraction and accommodation

690

1.01

0.01

1.3

1.4

5.50

5.47

mmol/l

0.12

653

Benign neoplasm of bone and articular cartilage

156

0.96

0.00

1.7

1.4

5.33

5.75

mmol/l

0.88

150

Stomatitis and related lesions

156

0.96

0.00

1.1

1.5

5.48

5.50

mmol/l

0.02

150

Benign neoplasm: Skin of eyelid, including canthus

274

1.02

0.00

1.4

1.3

5.40

6.01

mmol/l

2.58

256

All dysplastic lesions of the cervix uteri, vagina or vulva

107

1057

1.01

0.00

1.4

1.5

5.42

5.27

mmol/l

0.99

100

1009

First line medication for Crohn's disease

354

1927

1.00

0.00

1.3

1.4

5.74

5.54

mmol/l

1.55

331

1829

Conductive and sensorineural hearing loss

171

1180

1.00

0.00

1.2

1.3

5.91

mmol/l

0.03

159

1109

All-cause Heart Failure

648

1.00

0.00

1.2

1.3

6.25

6.15

mmol/l

0.39

607

Disorders of optic nerve and visual pathways

198

1.01

0.00

1.2

1.4

6.56

5.62

mmol/l

0.54

190

Other disorders of bladder

198

1.01

0.00

1.5

1.3

6.04

6.08

mmol/l

0.07

186

Other disorders of the musculoskeletal system and connective tissue

252

0.99

0.00

1.4

1.3

5.54

5.97

mmol/l

1.70

238

Carcinoma in situ of cervix uteri

322

0.99

0.00

1.4

1.6

5.46

5.13

mmol/l

1.43

308

Disorders of continuity of bone

175

0.97

0.00

1.6

1.4

5.58

5.76

mmol/l

0.30

167

ILD, hospital admissions 1, main diag only

195

0.97

0.00

1.4

1.2

6.09

6.16

mmol/l

0.08

184

Vitamin B12 deficiency anaemia

164

0.98

0.00

1.3

6.92

6.08

mmol/l

0.81

156

Other/unspecified synovitis and tenosynovitis

206

1.02

0.00

1.5

1.3

5.98

5.77

mmol/l

0.36

198

Injuries to the hip and thigh

792

1.01

0.00

1.2

1.3

5.75

5.85

mmol/l

0.39

745

Ulcer of oesophagus

102

0.98

0.00

1.0

1.2

6.43

6.01

mmol/l

—

Normotensive glaucoma

122

0.98

0.00

1.3

6.08

6.18

mmol/l

0.11

114

Palmar fascial fibromatosis [Dupuytren]

192

0.99

0.00

1.1

1.2

6.12

6.28

mmol/l

0.19

182

Noninflammatory disorders of female genital tract

184

923

1.00

0.00

1.4

1.5

5.29

5.20

mmol/l

0.68

168

890

COPD, hospital admissions 1, only main diagnosis

443

1.00

0.00

1.3

1.2

5.91

6.16

mmol/l

1.29

418

Adenocarcinoma and papilloma adenocarcinoma of rectum

141

0.99

0.00

1.1

1.2

5.94

6.19

mmol/l

0.39

134

Carcinoma in situ of cervix uteri

319

1.00

0.00

1.4

1.6

5.46

5.14

mmol/l

1.37

305

Crohn disease

299

1.00

0.00

1.5

1.4

5.43

5.59

mmol/l

0.37

284

Ulcerative colitis, NAS

319

1.00

0.00

1.3

1.4

5.55

5.61

mmol/l

0.13

302

Extrapyramidal and movement disorders

679

1.00

0.00

1.3

5.76

5.95

mmol/l

1.01

643

Cerebral aneurysm, nonruptured

147

1.02

0.00

1.2

1.3

5.87

6.04

mmol/l

0.25

140

Left bundle-branch block

1.01

0.00

1.2

1.3

6.00

6.31

mmol/l

—

Disorders of other and unspecified cranial nerves

0.00

0.0

1.2

—

6.63

—

Osteomyelitis of vertebra

0.00

0.0

1.2

—

10.68

—

Chromophobe cell carcinoma of kidney

0.00

0.0

1.1

—

8.91

—

Marasmic kwashiorkor

0.00

0.0

1.0

—

6.34

—

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

0.00

0.0

1.1

—

6.08

—

Malignant neoplasm of base of tongue

0.00

0.0

1.2

—

8.64

—

Pneumonia due to Haemophilus influenzae

0.00

0.0

1.2

—

10.79

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

0.00

0.0

1.0

—

10.34

—

Carcinoma in situ of breast

0.00

0.0

1.0

—

5.59

—

Injury of blood vessels at neck level

0.00

0.0

1.0

—

6.32

—

Other and unspecified localized connective tissue disorders

0.00

0.0

1.0

—

6.03

—

Intentional self-harm by smoke, fire and flames

0.00

0.0

1.0

—

6.36

—

Nondiabetic hypoglycaemic coma

0.00

0.0

1.2

—

5.71

—

0.00

0.0

1.1

—

8.24

—

Other specified/unspecified nutritional deficiencies

0.00

0.0

1.0

—

6.32

—

Disseminated intravascular coagulation [defibrination syndrome]

0.00

0.0

1.2

—

6.17

—

Benign neoplasm: Hypopharynx

0.00

0.0

1.2

—

9.34

—

Benign neoplasm: Mediastinum

0.00

0.0

1.0

—

6.20

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

0.0

1.2

—

10.90

—

Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.4

—

6.20

—

Malignant neoplasm of vulva

0.00

0.0

1.1

—

5.87

—

Filling of root of tooth

0.96

0.00

1.0

1.4

6.28

6.10

mmol/l

—

Contact with other and unspecified heat and hot substances

0.00

0.0

1.3

—

6.04

—

Hypertensive encephalopathy

0.00

0.0

1.2

—

6.51

—

Traumatic amputation of lower leg

0.00

0.0

1.1

—

9.24

—

Benign neoplasm: Epididymis

0.00

0.0

1.3

—

8.86

—

Other and unspecified medical devices associated with adverse incidents

0.00

0.0

1.1

—

9.16

—

Contact urticaria

0.00

0.0

1.1

—

5.87

—

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

9.27

—

Rheumatic fever with heart involvement

0.00

0.0

1.0

—

6.21

—

Lymphangioma, anys site

0.00

0.0

1.1

—

5.88

—

Rapidly progressive nephritic syndrome

0.00

0.0

1.0

—

6.48

—

Use of riluzole

0.00

0.0

1.0

—

6.51

—

Alpha thalassaemia

0.00

0.0

1.3

—

6.07

—

Exposure to uncontrolled fire, not in building or structure

0.00

0.0

1.2

—

9.56

—

Systemic disorders of connective tissue in diseases classified elsewhere

0.00

0.0

1.0

—

6.33

—

Hypersensitivity angiitis

0.00

0.0

1.0

—

6.77

—

Other degenerative disorders of eyelid and periocular area

0.00

0.0

1.2

—

6.42

—

Other and unspecified neuropathies

0.00

0.0

1.0

—

6.12

—

Renal agenesis and other reduction defects of kidney

0.00

0.0

1.2

—

5.98

—

Marfan's syndrome

0.00

0.0

1.2

—

5.93

—

Other congenital musculoskeletal deformities

0.00

0.0

1.3

—

5.32

—

Other congenital malformations of brain

0.00

0.0

1.3

—

5.35

—

Other and unspecified papulosquamous disorders

0.00

0.0

1.0

—

6.54

—

Vascular dementia (multiple infarctions)

0.00

0.0

1.3

—

6.51

—

Abnormal pulmonary venous return

0.00

0.0

1.0

—

6.00

—

Alcoholic cardiomyopathy

0.00

0.0

1.2

—

10.66

—

Injury of nerves and spinal cord at thorax level

0.00

0.0

1.0

—

6.26

—

Atrioventricular septal defect

0.00

0.0

1.3

—

5.98

—

Fetus and newborn affected by maternal complications of pregnancy

0.00

0.0

1.2

—

4.92

—

Other and unspecified atrophic disorders of skin

0.00

0.0

1.2

—

5.49

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.0

1.0

—

8.81

—

Amoebiasis

0.00

0.0

1.1

—

8.18

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

0.0

1.4

—

5.11

—

Osteopathy in diseases classified elsewhere

0.00

0.0

1.1

—

9.39

—

Carcinoma in situ of endometrium

0.00

0.0

1.0

—

5.85

—

Benign neoplasm: Heart

0.00

0.0

1.0

—

8.62

—

Knuckle pads

0.00

0.0

1.3

—

9.63

—

Kissing spine

0.00

0.0

1.2

—

6.52

—

Other specified acquired deformities of limbs

0.00

0.0

1.4

—

6.11

—

Radiodermatitis

0.00

0.0

1.0

—

5.95

—

Other and unspecified parapsoriasis

0.00

0.0

1.0

—

10.34

—

Female pelvic inflammatory disorders in diseases classified elsewhere

0.00

0.0

2.3

—

4.90

—

Other hypertrichosis

0.00

0.0

1.2

—

5.30

—

Erythema in diseases classified elsewhere

0.00

0.0

1.0

—

5.73

—

Cholinergic urticaria

0.00

0.0

1.2

—

5.58

—

Livedoid vasculitis

0.00

0.0

1.0

—

10.62

—

Oral lichen ruber planus, including avohilmo

100

1.00

0.00

1.1

1.4

5.48

5.98

mmol/l

—

Collapsed vertebra, not elsewhere classified

0.00

0.0

1.3

—

6.60

—

Perforation of oesophagus

0.00

0.0

1.1

—

6.29

—

Impaction of intestines

0.00

0.0

1.1

—

8.72

—

Frontotemporal dementia

0.00

0.0

1.1

—

6.60

—

Hyperhidrosis

0.91

0.00

1.2

1.5

5.92

5.62

mmol/l

—

Congenital lactase deficiency

0.00

0.0

1.2

—

5.71

—

Acquired atrophy of ovary and fallopian tube

0.00

0.0

1.3

—

5.58

—

Liver disorders in diseases classified elsewhere

0.00

0.0

1.0

—

5.59

—

Hypertension, portal

0.00

0.0

1.0

—

10.32

—

Vitreous prolapse

0.00

0.0

1.0

—

5.64

—

Cardiomyopathy in other diseases

0.00

0.0

1.0

—

10.16

—

Otorrhagia

0.00

0.0

1.1

—

9.40

—

Other specified/unspecified diseases of inner ear

0.00

0.0

1.0

—

6.25

—

Mild or no visual impairment, binocular

0.00

0.0

1.0

—

9.06

—

Other specified/unspecified disorders of ear

0.00

0.0

1.2

—

9.02

—

Other and unspecified disorders of orbit

0.00

0.0

1.0

—

6.43

—

Glaucoma secondary to drugs

0.00

0.0

1.0

—

9.80

—

Thyrotoxicosis factitia

0.00

0.0

1.0

—

6.21

—

Other and unspecified abdominal hernia

0.96

0.00

1.4

1.3

6.06

6.37

mmol/l

—

Food allergy

0.00

0.0

1.0

—

5.82

—

Hydrocephalus in other diseases

0.00

0.0

1.0

—

9.04

—

Lesion of medial popliteal nerve

0.00

0.0

1.2

—

9.93

—

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.0

1.1

—

8.89

—

Sleepwalking [somnambulism]

0.00

0.0

1.3

—

5.85

—

Mental and behavioural disorders due to hallucinogens

0.00

0.0

1.2

—

6.17

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

0.0

1.1

—

8.56

—

Magnesium deficiency

0.00

0.0

1.1

—

9.27

—

Implicit parasitic Sepsis

0.00

0.0

1.1

—

8.92

—

Effects of air pressure and water pressure

0.00

0.0

1.0

—

8.60

—

Hypothyroidism, autoimmune, DX-based

0.00

0.0

1.2

—

5.91

—

Disorders of puberty, other/unspecified

0.00

0.0

1.6

—

5.03

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.0

1.2

—

10.38

—

Disorders of purine and pyrimidine metabolism

0.00

0.0

1.0

—

8.95

—

Lipomatosis, not elsewhere classified

0.00

0.0

1.0

—

5.98

—

Cleft lip and palate

0.00

0.0

1.0

—

6.15

—

Malignant neoplasm of thymus

0.00

0.0

1.1

—

6.55

—

Adrenogenital disorders

0.00

0.0

1.0

—

6.18

—

Drug-induced gout

0.00

0.0

1.0

—

10.38

—

Other and unspecified diseases of spleen

0.00

0.0

1.0

—

9.04

—

Other disorders of adrenal gland

0.89

0.00

1.1

1.5

8.43

5.91

mmol/l

—

Disorders of amino-acid transport

0.00

0.0

1.0

—

10.05

—

Selective deficiency of immunoglobulin A [IgA]y

0.00

0.0

1.2

—

9.85

—

Histrionic personality disorder

0.00

0.0

1.0

—

5.94

—

Other and unspecified water transport accidents

0.00

0.0

1.0

—

9.15

—

Familial erythrocytosis

0.00

0.0

1.0

—

8.81

—

Other nutritional anaemias

0.00

0.0

1.1

—

8.86

—

Carcinoma in situ of vagina

0.00

0.0

1.0

—

5.49

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.0

1.0

—

6.19

—

Carcinoma in situ of middle ear and respiratory system

0.00

0.0

1.1

—

6.35

—

Benign neoplasm: Prostate

0.00

0.0

1.3

—

9.36

—

Benign neoplasm: Scrotum

0.00

0.0

1.3

—

9.46

—

Neuroendocrine tumor and carcinoma of stomach

0.00

0.0

1.0

—

9.60

—

Benign neoplasm: Lower jaw bone

0.00

0.0

1.0

—

6.29

—

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

6.03

—

Benign neoplasm: Central nervous system, other parts/unspecified

0.00

0.0

1.0

—

6.50

—

Benign neoplasm: Floor of mouth

0.00

0.0

1.2

—

6.53

—

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

10.03

—

Benign neoplasm: Epididymis

0.00

0.0

1.0

—

9.90

—

Benign neoplasm: Lymph nodes

0.00

0.0

1.2

—

6.12

—

Malignant neoplasm of retroperitoneum and peritoneum

0.00

0.0

1.0

—

5.98

—

Malignant neoplasm of meninges, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

6.13

—

Pseudomembranous colitis

0.00

0.0

1.0

—

5.87

—

Malignant neoplasm of thymus, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

6.37

—

Chromophobe cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

9.34

—

Malignant neoplasm of nasopharynx

0.00

0.0

1.0

—

9.23

—

Other epidermal thickening

0.88

0.00

1.3

5.28

6.08

mmol/l

—

Adenocarcinomas of cervix

0.00

0.0

1.0

—

5.74

—

Malignant neoplasm of other and ill-defined digestive organs

0.00

0.0

1.1

—

6.56

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

0.0

1.0

—

9.55

—

Liposarcoma

0.00

0.0

1.2

—

6.28

—

Alkalosis

0.00

0.0

1.2

—

6.37

—

Mucinous and mucinous cystic tumor of rectum

0.00

0.0

1.2

—

10.37

—

Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

5.82

—

Enduring personality changes

0.00

0.0

1.0

—

5.76

—

Osteosarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

6.58

—

Femoral hernia, bilateral

0.00

0.0

1.0

—

9.19

—

Neuroendocrine tumor and carcinoma of rectum, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

6.21

—

Malignant neoplasm of renal pelvis

0.00

0.0

1.2

—

9.92

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

0.00

0.0

1.1

—

6.27

—

Crushing injury of forearm

0.00

0.0

1.4

—

6.36

—

Congenital hydrocephalus

0.00

0.0

1.3

—

5.91

—

Other and unspecified disorders of lacrimal system

0.00

0.0

1.0

—

6.04

—

Benign neoplasm: Hypopharynx

0.00

0.0

1.2

—

10.23

—

Chloasma

0.00

0.0

1.0

—

5.75

—

Inhalation of gastric contents

0.00

0.0

1.0

—

9.47

—

Complications of anaesthesia during labour and delivery

0.00

0.0

1.8

—

5.08

—

Carcinoma in situ of endometrium

0.00

0.0

1.0

—

5.91

—

Other disorders of amino-acid metabolism

0.00

0.0

1.0

—

8.80

—

Vascular dementia (other)

0.00

0.0

1.5

—

6.60

—

Other endophthalmitis

0.00

0.0

1.1

—

6.42

—

Moderate visual impairment, monocular

0.00

0.0

1.1

—

8.84

—

Benign neoplasm: Pineal gland

0.00

0.0

1.4

—

5.30

—

Carcinoma in situ of vagina

0.00

0.0

1.0

—

5.28

—

Syndrome of inappropriate secretion of antidiuretic hormone

0.00

0.0

1.0

—

6.53

—

Carcinoma in situ of middle ear and respiratory system

0.00

0.0

1.2

—

6.36

—

Melanoma in situ, other sites/unspecified

0.00

0.0

1.0

—

6.20

—

Congenital malformations of great veins

0.00

0.0

1.4

—

5.78

—

Other proliferative retinopathy

0.00

0.0

1.0

—

6.18

—

Benign neoplasm: Scrotum

0.00

0.0

1.3

—

8.91

—

Carcinoma in situ of breast

0.00

0.0

1.0

—

5.63

—

Benign neoplasm: Rectum/anal canal icd-9

0.00

0.0

1.1

—

8.63

—

Benign neoplasm: Prostate

0.00

0.0

1.3

—

9.85

—

Benign neoplasm: Connective and other soft tissue of thorax

0.00

0.0

1.0

—

6.44

—

Benign neoplasm: Heart

0.00

0.0

1.0

—

8.68

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

0.0

1.0

—

5.52

—

Cholera

0.97

0.00

1.2

1.3

6.09

6.15

mmol/l

—

Benign neoplasm: Lymph nodes

0.00

0.0

1.2

—

6.37

—

Severe visual impairment, binocular

0.00

0.0

1.0

—

6.59

—

Benign neoplasm: Floor of mouth

0.00

0.0

1.2

—

6.33

—

Endometriosis of intestine

0.89

0.00

1.0

1.5

5.02

5.11

mmol/l

—

Lymphangioma, anys site

0.00

0.0

1.1

—

5.76

—

Benign neoplasm: Extrahepatic bile ducts

0.00

0.0

1.2

—

6.27

—

Moderate mental retardation

0.00

0.0

1.2

—

9.63

—

0.00

0.0

1.2

—

6.84

—

Right side

0.00

0.0

1.2

—

9.82

—

Left side

0.00

0.0

1.2

—

10.28

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

0.0

1.2

—

9.93

—

0.00

0.0

1.0

—

5.87

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

0.0

1.0

—

10.13

—

Acute mastoiditis

0.00

0.0

1.0

—

6.10

—

Nonadministration of surgical and medical care

0.00

0.0

1.0

—

6.01

—

Intentional self-harm by sharp object

0.86

0.00

1.4

1.5

5.18

5.63

mmol/l

—

Exposure to ignition of highly flammable material

0.00

0.0

1.2

—

9.80

—

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.0

1.3

—

5.87

—

Contact with blunt object, undetermined intent

0.00

0.0

1.1

—

8.94

—

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.0

1.0

—

9.47

—

Exposure to other and unspecified forces of nature

0.00

0.0

1.1

—

5.95

—

Exposure to excessive heat of man-made origin

0.00

0.0

1.2

—

6.52

—

Exposure to controlled fire, not in building or structure

0.00

0.0

1.0

—

6.48

—

Tracheo-bronchomalasia

0.00

0.0

1.4

—

5.13

—

Benign neoplasm: Lower jaw bone

0.00

0.0

1.0

—

6.29

—

Other effects of reduced temperature

0.00

0.0

1.0

—

6.59

—

Injury of blood vessels at lower leg level

0.00

0.0

1.0

—

6.62

—

Injury of blood vessels at hip and thigh level

0.00

0.0

1.0

—

6.59

—

Corrosions classified according to extent of body surface involved

0.00

0.0

1.0

—

5.88

—

Injury of blood vessels at abdomen, lower back and pelvis level

0.00

0.0

1.0

—

10.72

—

Vascular dementia (sudden onset)

0.00

0.0

1.0

—

6.68

—

Injury of blood vessels of thorax

0.00

0.0

1.2

—

6.42

—

Injury of blood vessels at forearm level

0.00

0.0

1.4

—

6.08

—

Oher contracture of tendon (sheath)

0.00

0.0

1.2

—

9.98

—

Leiomyosarcoma

0.00

0.0

1.1

—

8.66

—

Enterobiasis

0.00

0.0

1.3

—

5.62

—

Unspecified urinary incontinence

140

1.00

0.00

1.5

1.4

6.05

5.93

mmol/l

0.17

133

Traumatic amputation of ankle and foot

0.00

0.0

1.2

—

10.50

—

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

6.17

—

Complications following myocardial infarction

0.00

0.0

1.0

—

8.85

—

Cachexia

0.00

0.0

1.4

—

8.90

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

0.00

0.0

1.0

—

9.88

—

Acute hepatitis A

0.00

0.0

1.0

—

8.89

—

Cholesteatoma of external ear

0.00

0.0

1.0

—

8.54

—

Pediculosis and phthiriasis

0.00

0.0

1.8

—

9.62

—

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.2

—

6.87

—

Malignant neoplasm of palate

0.00

0.0

1.0

—

10.38

—

Malignant neoplasm of gum

0.00

0.0

1.1

—

6.43

—

Neuroendocrine tumor and carcinoma of rectum

0.00

0.0

1.0

—

6.19

—

Malignant neoplasm of penis, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

9.90

—

Normal-pressure hydrocephalus

0.89

0.00

2.4

1.2

6.42

6.48

mmol/l

—

Malignant neoplasm of nasopharynx, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

8.49

—

Malignant neoplasm of adrenal gland

0.00

0.0

1.0

—

6.42

—

Malignant neoplasm of anus and anal canal

0.00

0.0

1.0

—

6.54

—

Acute drug-induced interstitial lung disorder

0.00

0.0

1.0

—

9.60

—

Cardiomyopathies, Secondary/extrinsic

0.00

0.0

1.0

—

9.21

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

0.00

0.0

1.0

—

9.14

—

Other infiltrative disorders of skin and subcutaneous tissue

0.00

0.0

1.1

—

9.06

—

Listeriosis

0.00

0.0

1.0

—

10.34

—

Maze procedure for atrial fibrillation

0.00

0.0

1.1

—

9.49

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

0.0

1.1

—

6.11

—

Benign neoplasm: Connective and other soft tissue of thorax

0.00

-0.00

0.0

1.0

—

6.27

—

Squamous cell neoplasms and carcinoma of cervix, excluding all cancers (controls excluding all cancers)

0.00

-0.00

0.0

1.1

—

5.58

—

Squamous cell neoplasms and carcinoma of cervix

0.00

-0.00

0.0

1.1

—

5.64

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glucose [Moles/volume] in Serum or Plasma --baseline

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS